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Executive
Main points
• Traditionally the objective of drug policy has been to maintain
people in, or restore people to, a drug-free lifestyle. The aim
of health promotion programmes is to prevent persons, in
particular young people, from becoming drug users and to
provide people who are already using drugs with the
treatment and support to bring them to the stage where they
can stop using drugs.  Policy and practice have changed over
the past ten years and harm reduction is now a key feature of
Irish drug policy.
• As a result of decisions on measures to reduce the demand
for drugs taken by the Irish Government in 1996 and 1997,
new national, regional and local structures were established in
order to direct and co-ordinate drug policy.  These initiatives
have brought about a shift in approaches to the drug problem.
There is now more emphasis on the greater involvement of
community groups in the structural and organisational
implementation of drug policies.  This is accompanied by a
more holistic intersectoral approach involving the co-
ordination of drugs programmes and services at local level,
the involvement of communities in the development and
delivery of locally based strategies to reduce the demand for
drugs, and the focusing of actions on tackling the problem in
communities where it is most severe.
• The official response in the area of criminal justice is
characterised by legislative changes.  These changes, while
not solely concerned with drug issues, include seven-day
detention and restrictions regarding the right to silence in drug
ix
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trafficking cases, the seizure of criminal assets, an increase in
policing, the appointment of extra court judges, the provision
of extra prison places, and the setting up of a special unit to
target the assets of suspects.  In addition a referendum was
held to change the constitution in relation to bail laws which
indirectly concerns drug offences.
• There has been an expansion of drug treatment services, in
the Dublin area particularly, in response to the needs of
intravenous drug users and other special groups such as
young heroin smokers and users of ecstasy.
• A number of core information sources exists in Ireland to
evaluate the drug situation and inform policy making.
Foremost amongst these is the National Drug Treatment
Reporting System run by the Drugs Research Division of the
Health Research Board.
Most important trends and new developments
• Schools survey data indicate that there has been an increase
in the consumption of drugs, in particular cannabis.
• Problematic drug use continues to be associated with social
disadvantage.  The profile of the typical drug user who
presents for treatment and as represented in the statistics
over a number of years is significant - that of young,
unemployed male, leaving school at an early age and living in
a socially disadvantaged area.
• The drug profile of clients who present for treatment shows
that heroin is the main drug of misuse.  
• In 1996, 81 percent of those presenting for treatment for the
first time were less than twenty five years old, compared to 69
percent in 1990.
• There has been a shift in the risk behaviour of problem drug
users.  National data for 1995 and 1996 show that clients
coming into treatment for the first time were less likely to be
injecting their primary drug of misuse than was the case in
previous years.  This could be explained by the fact that  there
is an increase in the practice of smoking heroin among an
x
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increasingly young treated population and to the possible
efficacy of health education initiatives.
• Intravenous drug users make up a high proportion of
confirmed cases of AIDS in Ireland (42 percent in 1996).  The
proportion, which has decreased slightly over the years since
recording commenced in the mid 1980s, peaked in 1993 at 62
percent.
• A drug-related diagnosis was recorded for 3 percent of all
admissions to Irish psychiatric hospitals and units in 1996.
• Between 1992 and 1996 there was an increase in the number
and quantity of drugs seized, particularly heroin, cocaine and
amphetamines.  The number of ecstasy seizures has
increased over the years, very significantly so in 1995.
• The Drugs Research Division of the Health Research Board is
undertaking a nationwide survey on ‘Attitudes, Knowledge
and Beliefs in relation to Drug Misuse and Drug Misusers’.
The results of this study will provide much needed input to
public policy and perceptions.
New information needs and priorities for the future
• The National Drug Treatment Reporting System provides
information on the uptake of services and the development of
profiles of drug users contacting treatment services.  In
addition data on clients receiving treatment for the first time
can indicate changing patterns of problem drug use.  It is
planned to expand the National Drug Treatment Reporting
System to accommodate the increased provision of treatment
services and to include treatment provided by General
Practitioners and the Prison Services.  A future development
would be an assessment of the quality of the data by way of
a reliability and validity study.
• Recent reports of an escalation of the smoking of heroin
among young adolescents would indicate that an investigation
of motivations involved is needed.   
• Information in the areas of viral hepatitis and non-fatal
emergencies is limited and needs to be evaluated and its
collection needs to be more systematic and standardised.
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• Regular surveys of young people are necessary in order to
uncover drug using trends among this cohort.
• Research is needed to establish to what extent there is a link
between illicit drugs and crime, and what impact the
importation, sale and consumption of illegal drugs has on
crime.
• There is a need for on-going evaluation research into the
implementation of policy in all areas.  Investigation into the
implications of illicit drugs policy on health, on the economy,
on the criminal justice system are needed.  Evaluation studies
into the effectiveness of prevention programmes,
rehabilitation programmes, the outcomes of treatment and
methadone maintenance programmes need to be conducted.
The impact of media campaigns needs to be assessed.
Policy makers need this information in order to make informed
decisions in relation to demand and supply reduction
strategies.
Introduction
This report provides an overview of issues related to drug
misuse in Ireland.  The term drug misuse as used in this report
refers to the taking of a legal and/or illegal drug which harms the
physical, mental or social well-being of the individual, the group
or society.  Part I of the report outlines policy approaches to
drugs, relevant legislation, organisational, and operational
structures for the implementation of drug policy and legislation.
Part II provides a summary of drug monitoring systems and
sources of information on drugs in Ireland.  It summarises
epidemiological information and overviews issues related to the
availability and supply of drugs.  Part III provides a summary of
measures taken to reduce the demand for drugs at national and
regional levels and outlines specific intervention programmes
and initiatives e.g. school/community/outreach programmes.
The report focuses in particular on issues which arose in the
course of 1997.
The report thus provides a general overview of the situation in
Ireland regarding different aspects of the drugs phenomenon. It
is a unique reference source which will be of value to a number
of parties interested in the drug situation in the Irish context.
The report is based on work carried out by the Drugs Research
Division of the Health Research Board for the European
Monitoring Centre for Drugs and Drug Addiction - EMCDDA.
The EMCDDA is an European Union institution providing
information concerning drugs and drug addiction and their
consequences.  The EMCDDA works to improve the
comparability of drug related data in the Member States; to
disseminate information and co-operate with international
xiii
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bodies dealing with drug related issues.  The EMCDDA in
fulfilling its role, co-operates with a network of ‘Focal Points’ or
national centres dealing with drug related issues in the Member
States. This network is called the REITOX network (European
Information Network on Drugs and Drug Addiction).  The Drugs
Research Division is the designated Irish Focal Point of the
REITOX network.  Focal Points act as an information resource
to the EMCDDA in relation to the national situation in each
Member State and disseminate European level information
nationally. 
The Drugs Research Division completes an annual National
Report on Drug Issues in Ireland1 as part of its contractual
obligations to the EMCDDA.  This is the basis of the present
report.  The EMCDDA provides detailed guidelines for the
completion of the report along with a listing of the contents to be
covered.  However, as the different sections of this report for the
EMCDDA are designed to stand alone, some repetition of
background information is inevitable.  The present report is an
edited version of the report prepared for the EMCDDA i.e. edited
to minimise repetition and to emphasise issues of particular
interest in the Irish context. 
The time and resources allocated to the report of necessity
were limited, so no claim to complete
coverage/comprehensiveness is made.  Accordingly, the report
is presented as a Resource Document and comments on the
report are welcome.  Welcome in particular are updates to the
information provided.2
xiv
1 National Report on Drug Issues : Ireland 1997. Internal Report, Drugs Research Division, HRB
2 Please send such comments to the authors at, Drug Research Division, Health Research Board, 73 Lower
Drug Policy:
Legal and
Part I

Drug Policy
1.1 Historical background
In a policy document on mental health in 1966 (Report of the
Commission of Inquiry on Mental Illness) it was concluded that
Ireland had, as yet, avoided serious drug use and addiction
problems but advised that this could change unless constant
efforts were made to avoid the misuse of drugs.  In 1966 clinical
evidence for the existence of amphetamine dependence was
established (Walsh, 1966).  At the time it was not difficult to get
large amounts of amphetamines over the counter in many
pharmacies in Ireland.  Two years later public disquiet at the
increasing indications of drug misuse in Dublin resulted in the
setting up of the Garda Drug Squad and in the following year,
1969, the National Advisory and Treatment Centre was
established at Jervis Street Hospital. This was the first statutory
outpatient treatment facility in the country.
The principal components of Irish drug policy were contained
in the Report of the Working Party on Drug Abuse which was
published in 1971.  The Working Party, appointed by the Minister
for Health to examine the extent of drug misuse in Ireland,
concluded that there had been a change in the pattern of drug
use.  In 1969 the police were aware of 350 persons in the Dublin
area involved in the misuse of drugs.  By 1970 this figure had
grown to approximately 940 and estimates of up to 2,000 were
put forward by the Gardaí (Report of the Working Party on Drug
Abuse, 1971).  Whereas initially the drugs involved in
discussions about drug problems included amphetamines,
barbiturates and tranquillisers, at the end of the 1960s the most
commonly misused drugs were cannabis and LSD (lysergic acid
3
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diethylamide).  There was no evidence of any significant use of
heroin. The problem of drug use had steadily increased in size
in the Dublin area and it was recommended that the position
should not be viewed with complacency.  The enactment of the
Misuse of Drugs Act, 1977 was a significant development during
the 1970s.  It provided for a wide range of controls over drugs
which are liable to misuse (see Chapter 2).
Commencing in 1980 there was a sudden and dramatic rise in
the use of opiates by young people in the inner city areas of
Dublin.   The onset of the heroin epidemic, as it subsequently
became known, occurred later in Dublin than in other European
cities.  A number of measures were introduced as a direct result
of the recommendations of two reports at this time (Eastern
Health Board Task Force, 1982; Special Government Task
Force on Drug Abuse, 1983).   These included legislative
changes, the introduction of ‘life skills’ programmes in a number
of schools, the establishment of a diploma course in Addiction
Studies at Trinity College, Dublin and the setting up of a National
Co-ordinating Committee on Drug Abuse.
The National Co-ordinating Committee on Drug Abuse was
established in 1985 to monitor developments and to advise the
Government on issues regarding the prevention and treatment
of drug misuse.  In the late 1980s, amid increasing concern
about the AIDS epidemic and in the interest of public health, the
existing abstinence model of treatment was extended to include
a harm reduction approach in order to minimise the risks
involved.  This included decentralised structures for drugs
programmes relating to demand reduction, treatment and
rehabilitation.  The National Co-ordinating Committee on Drug
Abuse was reconstituted in 1990 and charged with the
responsibility of developing a policy to prevent drug misuse.
The ensuing report the following year was adopted to become
the Government Strategy to Prevent Drug Misuse (National Co-
ordinating Committee, 1991).
Up to 1996 responsibility for co-ordinating the development
and monitoring of the Government Strategy to Prevent Drug
Misuse (ibid.) lay with the Ministers for State at the then
4
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Departments of Health and Justice and implemented through
the National Co-ordinating Committee on Drug Abuse. The fight
against drug trafficking and drug misuse was a major theme of
the Irish Presidency of the European Union during 1996.    
In recent years with the escalation of the ‘drug problem’ and
the perceived associated criminal activity, attitudes towards drug
traffickers and pushers have hardened considerably, in
particular following the murder of an investigative journalist
during the summer of 1996, allegedly by criminals involved in
drug trafficking.
1.2 Philosophy, objectives, principal
components of drug policy 
The official attitude to people who become dependent on drugs
was articulated in 1971 by the then  Minister for Health in an
address to the Working Party on Drug Abuse when he said that
they ‘should be regarded as sick people in need of medical care
to be treated with sympathy and understanding and be helped in
every way possible to overcome their dependency on drugs’
(Report of the Working Party on Drug Abuse, 1971).  Drug
traffickers on the other hand were regarded as deserving no
sympathy ‘and should be punished to the full extent permitted by
law’ (ibid.).   Broadly speaking, this is still the attitude underlying
current drug policy.  Drug taking and the criminal activity
associated with it, is considered to be a very serious social
issue.
Traditionally the objective of drug policy has been to maintain
people in, or restore people to a drug-free lifestyle.  The
promotion of health is emphasised in prevention programmes
provided by education and health services.  The aim of health
promotion programmes is to prevent persons, in particular
young people, from becoming drug users and to provide people
who are already using drugs with the treatment and support to
bring them to the stage where they can stop using drugs.  While
a drug-free society is the ultimate ideal, it is acknowledged that
this is not an option for many drug users, at least in the initial
stages of treatment.  Since the mid 1980s, when the link
5
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between needle sharing and the transmission of HIV was first
recognised, a more pragmatic approach has been taken.  As
well as the provision of a number of treatment options, the
importance of the minimisation of risk behaviour is stressed in
prevention programmes provided by health and education
services, and in treatment, harm reduction and rehabilitation
programmes provided by the health services.  The Government
Strategy to Prevent Drug Misuse (National Co-ordinating
Committee, 1991) recognised that the treatment, care and
management of drug misuse does not lend itself to a ‘one
solution’ approach.  Consequently, there is a number of
treatment and rehabilitation programmes available through a
variety of agencies e.g., the Eastern Health Board, the Drug
Treatment Centre Board, the voluntary sector and through
primary care doctors.  These programmes are closely aligned
with the national AIDS strategy.  Prevention, treatment and
rehabilitation activities are balanced by measures taken in the
area of law enforcement.
1.3 New developments
Following the recommendations of the First Report of the
Ministerial Task Force on Measures to Reduce the Demand for
Drugs (1996) new structures were introduced to direct and co-
ordinate drug policy.  The operational implementation of
approaches to drugs issues has now devolved from the National
Co-ordinating Committee on Drug Abuse to a more structured
sectoral approach involving A Cabinet Committee on Social
Inclusion and Drugs, A National Drugs Strategy Team, A
Regional Co-ordinating Committee and Local Drugs Task
Forces (see Co-ordination of Drug Policy in Chapter 3).  A
number of legislative changes were introduced to curb the
supply of and the demand for drugs.  A new statutory body, the
Criminal Assets Bureau (CAB), was established to ensure closer
and more concerted action between state agencies in targeting
the illegally acquired assets of criminals involved in serious
crime, including drug trafficking.   
The Second Report of the Ministerial Task Force on Measures
to Reduce the Demand for Drugs (1997) examined aspects of
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the drugs problem in Ireland, such as the misuse of non-opiate
drugs, drug use in prison, and the role of therapeutic
communities in the treatment and rehabilitation or drug users.
While it is generally acknowledged that problems associated
with the use of heroin are mainly confined to disadvantaged
areas in Dublin, this report states that the use of cannabis and
ecstasy is ‘nationwide’ and ‘is closely associated with youth
culture’ (ibid., p.52).  Recommendations focus mainly on
prevention activities.  With regard to drug use in prison it was
suggested that more integrated systems of supports as well as
consistency in treatment policies inside and outside of prison are
required.  The need for an independent assessment of the
effectiveness of current policies was acknowledged and it was
recommended that an expert group be established to examine
the issues involved.  On the role of therapeutic communities in
the treatment and rehabilitation of drug users it was
acknowledged that this model should form part of the range of
services available.  It was recommended that international
experience should be examined in determining the suitability of
different models of treatment.  The Ministerial Task Force
recommended the establishment of an advisory group for this
purpose and also to address the question of research.
As a result of the recommendations of the First and Second
Report of the Ministerial Task Force on Measures to Reduce the
Demand for Drugs (1996, 1997) and consequent structural
changes in the co-ordination of drug policy during 1997 (see Co-
ordination of Drug Policy in Chapter 3), a shift occurred in
drug policy approaches.  There is now more emphasis on the
greater involvement of community groups in the structural and
organisational implementation of drug policies.  This is
accompanied by a more holistic intersectoral approach (health,
education, housing, estate management, employment,
recreation, sport, policing, etc.) to the drug problem involving the
co-ordination of drugs programmes and services at local level,
the involvement of communities in the development and delivery
of locally based strategies to reduce the demand for drugs, and
the focusing of actions on tackling the problem in the
communities where it is most severe.
7

Relevant
2.1 Drug laws and penalties
In late 1996, Ireland ratified the UN Convention Against Illicit
Traffic in Narcotic Drugs and Psychotropic Substances; and the
Council of Europe Convention on Laundering, Search, Seizure
and Confiscation of the Proceeds of Crime.  These Conventions
require Convention States to co-operate in the area of criminal
law as well as to put in place certain domestic criminal law
provisions.  Since signing up to the Conventions, Ireland’s role
in international co-operation has significantly improved and
expanded.   
The following Acts and Regulations provide the statutory
framework for the control of drugs with potential for misuse.
Some of the legislation in this area predated the foundation of
the State.  The legislation is drawn up and implemented on an
inter-sectoral basis by the relevant government departments of
Health & Children, Justice, Equality & Law Reform and
Environment; the Garda Síochána, Revenue Commissioners
and Customs authorities.
The Poisons (Ireland ) Act, 1870 applied control to the sale of
scheduled poisons including opium, morphine, cocaine, heroin
and preparations containing these drugs.   
The Pharmacy Act (Ireland), 1875 confined the sale of
scheduled substances to authorised persons i.e. registered
pharmaceutical chemists.
The Dangerous Drugs Act, 1934 which was based on
international law controlled the import, export, distribution sale
9
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and possession of specified drugs.
The Medical Preparations (Control of Sale) Regulations,
1966 regulated the retail sale of amphetamines and their
analogues, barbiturates and tranquillisers and  limited these to
prescription only.
Under the Medical Preparations (Control of Amphetamines)
Regulations, 1969 & 1970 the manufacture, sale and
distribution of amphetamines and preparations containing
amphetamines or their derivatives were prohibited.
The Misuse of Drugs Acts, 1977 and 1984 and the
Regulations made thereunder provide for a wide range of
controls over drugs which are liable to misuse.  They include
controls relating to cultivation, licensing, administration, supply,
record-keeping, prescription-writing, destruction and safe
custody.  Included in the Acts are the provisions designed to
deal with the irresponsible prescribing of controlled drugs by
medical practitioners. 
Possession of any controlled drug, without due authorisation,
is an offence under Section 3 of the Principal Act (1977).
Section 15 of the same Act concerns the possession of a
controlled drug for the purpose of unlawful sale or supply.
Section 16 details the prohibition of certain activities relating to
opium.  The use of prepared opium, the frequenting of premises
used for the use of opium and the possession of utensils used
for smoking opium are all offences under this section.  Section 5
of the 1984 Act prohibits the printing or communication of certain
information which advocates or encourages the use of any
controlled drug.  
The penalties on being found guilty of an offence under
section 15 of the 1977 Act, range from a fine or imprisonment for
a term not exceeding twelve months or both on summary
conviction, to an unlimited fine or imprisonment for life or both on
conviction on indictment.  The maximum penalty for possession
of cannabis for personal use is restricted to a fine for first or
second offences tried on summary conviction.   For third and
10
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subsequent offences there is a  fine or twelve months in prison,
or both.   The penalty for a third offence on indictment is an
open-ended fine or three years in prison, or both.  The penalties
for the possession of other controlled drugs are harsher and
depend on the type of court in which the case is tried.  On
summary conviction the penalty is a fine or twelve months in
prison, or both.  On conviction on indictment the maximum fine
for possession is left to the discretion of the court, which may
also impose a seven-year prison sentence, or both a fine and a
prison sentence.   
Provision is made under the Acts for the judicial possibility in
‘certain cases to arrange for the medical or other treatment or for
the care’ of a  person dependent on drugs and convicted of an
offence under the Acts.
The Misuse of Drugs Act, 1977 (Controlled Drugs)
Declaration Order, 1987.  Statutory Instrument No. 251 of
1987 declares that certain substances, products and
preparations should be controlled drugs for the purposes of the
Misuse of Drugs Act, 1977.
The Criminal Justice Act, 1984 provides for a widening of the
scope of the criminal law and procedures to deal more
effectively with serious crime, including serious offences under
the Misuse of Drugs Acts.
The Misuse of Drugs Regulations, 1988. Statutory
Instrument No. 328 of 1988. This document sets out the
arrangement of the 1988 regulations regarding the misuse of
drugs.  Amongst other things the effect of the regulations is to
impose restrictions on the production, supply, importation and
exportation of the drugs to which the Misuse of Drugs Acts 1977
and 1984, apply.
Section 74 of the Child Care Act 1991 states that where a
shopkeeper sells a substance, in particular glue, likely to be
inhaled to cause intoxication to a minor, he/she can, on
conviction, be fined or imprisoned for up to twelve months.
There is a provision for the retailer to put forward a defence that
11
Overview of Drug Issues in Ireland, 1997
reasonable steps were taken to ensure that this was not a
deliberate offence.
The Misuse of Drugs Act, 1977 (Controlled Drugs)
Declaration Order, 1993. Statutory Instrument No. 328 of
1993 is published for the purpose of declaring the substances,
products and preparations which are controlled drugs under the
Misuse of Drugs Act, 1977.
The Misuse of Drugs (Scheduled Substances) Regulations,
1993 (Statutory Instrument No. 338 of 1993) was introduced
in November 1993 to control precursors and essential
chemicals. They are designed to meet Ireland’s obligations
relevant to the control of these substances, under the United
Nations Convention Against Illicit Traffic in Narcotic Drugs and
Psychotropic Substances 1988, and under EC Directives 92/109
and EC Regulation 3677/90. The Regulations control
production, supply, importation, exportation and possession of
the substances.
The Criminal Justice Act, 1994 provides for the seizure and
confiscation of assets derived from the proceeds of drug
trafficking and other offences. It contains provisions related to
money laundering and allows for international co-operation in
respect of certain criminal law enforcement procedures, the
forfeiture of property used in the commission of crime and
related matters.
The Criminal Justice (Drug Trafficking) Act, 1996 provides for
the detention of persons accused of drug trafficking offences for
up to seven days.   It also allows inferences to be drawn by a
court from the failure of an accused person to mention particular
facts during questioning.
Under the Criminal Assets Bureau Act, 1996 the Criminal
Assets Bureau was established on a statutory footing with
powers to focus on the illegally acquired assets of criminals
involved in serious crime.  The aims of the Bureau are to identify
the criminally acquired assets of persons and to take the
12
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appropriate action to deny such people of these assets.  This
action is taken particularly through the application of the
Proceeds of Crime Act, 1996.  
The Licensing (Combating Drug Abuse) Act, 1997 introduced
a number of measures allowing for the suspension of
intoxicating liquor licences and/or disqualification for ever from
obtaining an intoxicating liquor, a public dancing or a public
music and singing licence, following conviction for drug
offences, e.g. knowingly allowing consumption or sale of drugs
on premises.
The Europol Act, 1997 provides for the establishment of a
Europol National Unit and enables the ratification, by the State,
of the Europol Convention and related protocols.  This
Convention establishes a European Police Office (Europol) to
improve the effectiveness of and co-operation between Member
States in preventing and combating serious international crime
involving two or more Member States.  It provides for a
progressive development of the types of crimes in respect of
which Europol will have competence and which will include
within Europol’s initial remit unlawful drug trafficking offences.
Once the Convention enters into force Europol will effectively
replace the Europol Drugs Unit (EDU).
2.2 Other relevant laws
The following are statutes indirectly related to the control of
drugs.
The Customs Consolidation Act, 1876 was a consolidation of
all Customs legislation up to that time and concerns importation,
seizures, detention of goods and persons and arrests.
The Mental Treatment Act, 1945 provided for the compulsory
hospitalisation of ‘addicts to drugs’.  Addiction remains on the
statute books as one of the criteria for non-voluntary committal
to a psychiatric hospital, but in practice it tends not to be invoked
and one of the recommendations of the White Paper on Mental
Health, 1995 was that it be abolished.
13
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The Customs Act, 1956 ‘shall be construed as one with the
Customs Acts’ which means all enactments relating to the
Customs. It deals with the illegal importation and exportation of
goods.
The Customs and Excise (Miscellaneous Provisions) Act,
1988 amends and extends the law relating to customs and
duties of excise and to amend the law relating to certain
penalties for illicit distillation of spirits.  In conjunction with other
Customs and Excise Legislation, specifically 1876 and 1956, the
Customs and Excise (Miscellaneous Provisions) Act, 1988
provides the legal basis for customs controls.
The Data Protection Act, 1988 is designed to protect the
privacy of individuals with regard to automated ‘personal data’
(data relating to individuals who can be identified from the data).
This covers relevant information which is kept with regard to
drug users.  The legislation gives effect in Ireland to the Council
of Europe Data Protection Convention.
The Proceeds of Crime Act, 1996 provides for the freezing and
forfeiture of the proceeds of crime.  This legislation
complements the confiscation provisions of the Criminal Justice
Act, 1994.
The Disclosure of Certain Information for Taxation and
Other Purposes Act, 1996 provides for more effective
exchange of information between police and revenue where
there are reasonable grounds for suspecting that profits have
been gained from unlawful sources or activities.
The Children Bill, 1996 is primarily concerned with the
introduction of provisions which will allow for the creation and
development of a new juvenile justice system.  It proposes for
example, that the Garda Juvenile Diversion Programme, which
gives the opportunity to divert juvenile offenders from criminal
activity and to provide an alternative to their being processed
through the formal criminal justice system, would operate on a
statutory basis. It currently operates on an administrative basis.
14
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The Freedom of Information Act, 1997 enables members of
the public to obtain access to information in the possession of
public bodies and to have personal information relating to them
corrected.
The Bail Act, 1997 was enacted to give effect to the
amendment to the Constitution and also to tighten up on other
areas of the law in relation to the granting of bail.  It allows the
courts the discretion to refuse bail where they are satisfied that
there is a danger of the commission of serious offences by a
person while on bail.  The Act also includes a requirement that
an accused person and his/her surety lodge in court, in cash or
cash equivalent, a proportion of the amount set for bail.  It also
strengthens the provisions of the Criminal Justice Act, 1984 in
relation to the imposition of consecutive sentences for offences
committed on bail.  The Act is to come into operation by order to
be made by the Minister for Justice, Equality and Law Reform.
The Non-Fatal Offences Against the Person Act, 1997
provides a range of new offences to combat criminal conduct
involving syringes, including offences of possession of a syringe
or container of blood with intent to threaten or injure, placing or
abandoning a syringe in any place in a manner which injures or
is likely to injure any person, injuring a person with a syringe or
threatening to do so, and throwing or putting blood on another
person or threatening to do so.  The penalties range from five
years to life imprisonment.
The Housing (Miscellaneous Provisions) Act, 1997
introduced a number of measures designed to assist housing
authorities and approved voluntary housing bodies in
addressing problems arising on their estates from anti-social
behaviour, such as drug dealing.  The Act provides for a new
‘excluding order’ procedure against individual occupants of a
local authority house involved in anti-social behaviour, thereby
avoiding the need for eviction of entire households in certain
circumstances.   It also includes provisions for the police, on
notification by the housing authority to remove squatters who
15
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A diversity of agencies is involved in the administration of drug
policies in Ireland (see Figure 3.1).  A description of the
administrative structures follows brief notes on the statutory and
community actors.
3.1 Key actors, their roles, and relationships
between them
Department of Health and Children
The Department of Health & Children is responsible for the
overall policy and administration of all aspects of health and
social care in so far as they relate to public health and child
welfare.  The Department plays a central role in the
development of drug  treatment policies and services and has
adopted a health promotion approach.  This is based on
encouraging people to take responsibility for their health and on
providing the support necessary to achieve this. The relevant
legislative measures necessary to back up policies are drawn up
by the Department of Health & Children.
The Department along with Regional Health Boards is
responsible for the development of national and regional drug
prevention activities.  The Health Promotion Unit of the
Department formulates prevention policies and is involved in the
development of education and training programmes and the
publication and dissemination of information literature that
promotes the avoidance of drug misuse.  Overall responsibility
for the provision of treatment and rehabilitation services for
people addicted to drugs lies with the Regional Health Boards.
Department of Justice Equality and Law Reform
17
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The Department of Justice, Equality and Law Reform
administers the courts, prisons and the Garda Síochána in
discharging its primary function of preserving law and order.
This Department is responsible for the implementation of Irish
policy on the reduction of the supply of drugs.
All members of the Garda Síochána have a responsibility for
the enforcement of all aspects of the law, including the various
drug laws.  All Gardaí receive instruction and training in relation
to drugs including the enforcement of drug-related laws, the
procedures for dealing with drug cases, health and safety
issues.  The Garda National Drugs Unit was established in 1995
with the primary function of targeting major drug traffickers as
well as monitoring, controlling and evaluating all drug
intelligence and policies within the police force.  In addition to
the Garda National Drugs Unit, there are officers in local drug
units dealing solely with drugs matters.  Juvenile Liaison
Officers, who are specially trained Gardaí, have a role in drug
activities by giving lectures/talks to school-children, young
people and parents throughout the country.
The Department is further responsible, through the Probation
and Welfare Service, for the treatment and general welfare of
persons in prison.  In some areas of Dublin a major proportion
of Probation and Welfare Officers’ workloads relates to
offenders with significant drug misuse problems.
The Forensic Science Laboratory of the Department is
responsible for the analysis of illicit drugs seized by law
enforcement agencies.  Scientists there identify the type and
purity of drugs seized.  The laboratory is also involved in the
development of analytical techniques for the identification of
illicit substances.
Responsibility for data protection and other relevant
legislation also lies with the Department of Justice, Equality &
Law Reform.
Department of Education and Science
Through the formal education system the Department of
Education and Science plays a role in drug prevention
18
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programmes.  It works with the Department of Health & Children
and other agencies on the development of awareness and
information programmes in schools.  In 1994 a substance
misuse prevention programme On My Own Two Feet was
introduced in second level schools.  Training is provided to
teachers who participate in this programme.  An evaluation of
the rationale and effectiveness of the programme was carried
out and published in 1996 (Morgan et al., 1996).  A similar
programme for primary schools was developed during 1996 and
was piloted during 1997 in schools in priority areas.
Other Government Departments
During 1996 the Government established a Ministerial Task
Force to examine existing drug policy arrangements and to
identify measures to provide more effective responses to the
problem.  The membership of the Task Force comprised
Ministers of State from several Government Departments
including the then Health, Justice, Education, the Environment,
Foreign Affairs, Social Welfare, and the Taoiseach.  A report was
published making recommendations for structural and
administrative changes (First Report, 1996).  Following the
publication of the Second Report of the Ministerial Task Force
on Measures to Reduce the Demand for Drugs (1997) a Minister
of State at the Department of Tourism, Sport & Recreation was
given special responsibility for Local Development and for the
National Drugs Strategy. 
The Office of the Revenue Commissioners
The Office of the Revenue Commissioners is an administrative
entity separate from the Department of Finance but within the
area of responsibility of the Minister for Finance and includes the
Customs and Excise service.   The effectiveness of Customs
legislation, practices and procedures for detecting the illegal
importation or exportation of controlled drugs is kept under on-
going review.  The Customs National Drugs Team comprises
Intelligence, Operational, Maritime teams as well as Dog Units.
These are strategically located around the coast of Ireland in
efforts to prevent drug trafficking.
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Regional Health Boards
There are eight Regional Health Boards in Ireland (see map at
Annex A).  They have responsibility in their respective areas for
the development and implementation of health services, the co-
ordination of statutory and voluntary services, and the provision
of support and training for community groups involved in drug
prevention activities.   All Regional Health Boards have
established Regional Drugs Co-ordinating Committees and
many have also appointed Drug Co-ordinators.  Due to
increased demand in Dublin, prevention, treatment and
rehabilitation services are continually expanding in the Eastern
Health Board area.  A chart of the services provided by the
Eastern Health Board can be found at Annex D.  Treatment
services in the other health board areas are still mainly provided
by the general psychiatric service and some voluntary agencies.
Community Groups
Following Government decisions in October 1996, priority areas
with very serious drug problems have been identified and Local
Drugs Task Forces have been established to co-ordinate the
implementation of drug policy.  Membership of these Task
Forces is drawn from local health boards, the education service,
the local authority, the local employment service, the Probation
and Welfare Service, the Gardaí, and community and voluntary
organisations.  In recent times community groups are taking a
more active role in the formulation and implementation of policy.
The involvement of such groups will be facilitated by recent
increases in Exchequer financial allocations to the fight against
drugs.
Voluntary Organisations
Voluntary organisations play a key role in the development and
delivery of prevention and treatment programmes.  Many of
these receive support and funding from the regional Health
Boards in whose areas they operate in addition to voluntary
funding.
3.2 Co-ordination of drug policy
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A central aspect of the Strategy document of the Department of
Health & Children  Shaping a healthier future (1994: 48) was ‘a
health promotion approach based on encouraging people to
take responsibility for their own health’. In general health policy
terms, the importance of inter-sectoral collaboration is centrally
recognised.  One of the major tasks of drug policy is that of co-
ordinating the activities of a range of governmental sectors.
While this has been recognised the reality of inter-sectoral co-
ordination is problematic.  
Following Government decisions on measures to reduce the
demand for drugs new structures were introduced to direct and
co-ordinate drug policy.  The operational implementation of
approaches to drug issues operates on a sectoral basis and is
made up of the following:
A Cabinet Committee on Social Inclusion and Drugs, is
chaired by the Taoiseach.  The other members of the committee
are the Tanaiste and the Ministers for Finance; Health &
Children; Environment & Local Government; Justice Equality &
Law Reform; Education & Science; Social Community & Family
Affairs; Tourism Sport & Recreation and two Ministers of State
including one with specific responsibility for the National Drugs
Strategy.  This committee was originally named the ‘Cabinet
Sub-Committee on Drugs’ but had its brief broadened in 1997,
with the change in Government, to include Social Inclusion.
The Cabinet Committee on Social Inclusion and Drugs has
political responsibility for 
• the reviewing of trends in the drugs problem
• the assessment of progress in the Government’s strategy to
deal with both the supply and the demand aspects of
drug policy
• the resolving of policy or organisational difficulties which
may inhibit effective responses to the problem.
A National Drugs Strategy Team, comprising representatives
of relevant Government Departments, the Garda Síochána, FAS
(Training and Employment Authority), the community sector, a
voluntary organisation, and a medical advisor, was set up to
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oversee the implementation of the Ministerial Task Force
Reports.  The National Drugs Strategy Team functions at two
levels, policy and operational.   
At the policy level a Policy Team 
• reviews progress in the implementation of government
policy 
• addresses issues which may arise from the implementation
of
this policy.
This Team reports to the Cabinet Drugs Committee, more
recently the Cabinet Committee on Social Inclusion and
Drugs, on a regular basis and brings to its attention issues
requiring political direction or decision.
At the operational level an Operational Team
• ensures effective co-ordination between government
departments and statutory agencies in implementing
government policy
• oversees the work of the Local Drugs Task Forces and
assists them where necessary
• draws up guidelines to assist them in the preparation of
anti-drugs strategies
• evaluates these strategies and makes recommendations to
Government regarding the allocation of resources to
support
their implementation
• monitors developments at local level ensuring that central
government is aware of the problems and priorities of
communities.
• considers policy issues before referring them to the
Policy Team.  
Regional Co-ordinating Committees operate in each of the
eight regional health boards, with representation from the health
boards, the education service the gardaí and relevant voluntary
and community agencies.  
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Local Drugs Task Forces have been set up in priority areas in
the Eastern and Southern Health Board areas (12 in Dublin, 1 in
Cork) where heroin misuse is a serious problem, with
representation from the Eastern Health Board, the Southern
Health Board, the Garda Síochána, the Probation and Welfare
Service, the relevant Local Authority, the Education/Youth
Service and FAS (Training and Employment Authority) along
with community representatives nominated by the relevant
community groups, and a chairperson.  Voluntary agencies
delivering a drug service in the area are also invited to
participate.  A co-ordinator for each Task Force is provided by
the relevant Health Board.  The Local Drugs Task Forces were
established to provide a strategic locally-based response by
statutory, community and voluntary sectors to the drugs
problem, in the areas worst affected.  During 1997 they were
mandated to prepare service development plans to respond to
the drug problem and Government funding of £10 million was
made available to implement these plans.  Their mandate is:
• to compile a profile of existing and planned services and
the resources available
• to prepare a development strategy to deal with the local
problems
• to oversee the implementation of local drugs strategies
• to provide information, reports and proposals to the
National Drugs Strategy Team
The aim of these Local Drugs Task Forces is to falicitate
effective co-ordination of programmes and services at local
level, involving communities in the development and delivery of
locally-based anti-drugs strategies.  Their actions are focused
on drugs issues in communities where the problems associated
with drug use are most severe.  They are carrying out work in
the following  broad areas:
• Re-integration of drug misusers - this will involve the
provision of places on Community Employment/Community
Training Programmes
23
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The Department of Justice Equality and Law Reform, and the
Office of the Revenue Commissioners have overall
responsibility for the funding of law enforcement agencies - the
Garda Síochána, the Garda National Drugs Unit, the Probation
and Welfare Service, the prisons and the Customs and Excise
Service.
Extra funding of £10m was approved by government in 1997
to support the implementation of the recommendations of the
Ministerial Task Force on Measures to Reduce the Demand for
Drugs.   
3.4 New information requirements
regarding drug policy
In recent years in Ireland, there has been growing recognition of
the need for data and information on drug misuse which can
inform policy makers and service providers in relation to policy
and interventions.  Because of the relevance of data to policy
issues the information base needs development in a number of
directions.  Some of these developments are underway or
planned.  This interest was reflected in the Science and
Technology against Drugs Initiative which was launched in 1996.
This research programme was initiated by Forbairt and
conducted under the authority of the National Research Support
Fund Board.  A special research budget was provided to
researchers in third level institutions for a range of projects.
Eight social science projects are investigating the factors which
contribute to and inhibit drug taking.  Other projects funded
under this programme address the areas of Drug Detection and
Analysis, and Biochemistry and Pharmacology (for details of
projects, see Appendix C).  The requirements stemming from
1996 Ministerial Task Force on Measures to Reduce the
Demand for Drugs has resulted in the collection of some
background information on drug misuse in local areas.  This
information was collected in the context of the formulation of
local drug service development plans by Local Drugs Task
Forces  (as mandated by the 1996 report).
The Ministerial Task Force on Measures to Reduce the
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Demand for Drugs recommended the setting up of an Advisory
Group which would address policy and good practice in the
drugs area. Preliminary planning and resourcing of the Advisory
Group is under discussion.  The terms of reference and
membership of an Advisory Committee to review drug policies
and research are under consideration.
The National Drug Treatment Reporting System [NDTRS], run
by the Drugs Research Division of the Health Research Board
[HRB] provides nationwide information on treated drug misuse.
As such it is a major information source for policy makers,
researchers, practitioners and the general public.  With support
from the Department of Health and Children, inter alia, a
feasibility study is underway which it is planned will lead to the
expansion of the NDTRS to include coverage of treatment
provision in the prison services and by General Practitioners in
community settings.  Other studies nearing completion or
planned by the Division which will inform policy include - a study
of drug misuse in its social and economic context which is
focusing on the relationship between problematic drug use and
economic deprivation; a study of knowledge, attitudes and
beliefs of the general public regarding drugs.  In addition work
being undertaken by the Division in its collaborative associations
with the EMCDDA and the Pompidou Group of the Council of
Europe will provide background information for policy makers
and related actors (see Annex E).
Other policy-relevant work carried out in Ireland, includes a
study on prevalence of opiate addiction in the Dublin area
(publication due 1998).  The Department of Health and Children
has funded this research through the Health Research Board.
Ongoing studies of this nature will be required.
With increasing political concern about the causes and
consequences of drug usage, new policy initiatives and new
approaches to policy implementation are required.  The need for
data to inform the formulation and implementation of drug policy
is increasing.  Policy makers in addition need information on the
attitudes of society to drug use and the willingness of different
groups in society to support drug policy initiatives.  Information
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is required on, for example, models for resource allocation, the
effectiveness of drugs policies in different socio-economic
contexts, the role of actors from the different sectors, the
importance of capacity building in local communities, the
effectiveness of different treatment models and rehabilitation
programmes, the relapse rate of treated clients.  In addition, the
new area based approaches to tackling the drugs problem and
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Traditionally the objective of drug policy has been to maintain
people in, or restore people to, a drug-free lifestyle.  Policy and
practice have changed over the past ten years and harm
reduction is now a key feature of drug policy.
While it is acknowledged generally that problems associated
with the use of heroin are mainly confined to disadvantaged
areas in Dublin, the Second Report of the Ministerial Task Force
on Measures to Reduce the Demand for Drugs (1997) stated
that the use of cannabis and ecstasy is ‘nationwide’ and ‘is
closely associated with youth culture’.
As a result of the recommendations of the First and Second
Report of the Ministerial Task Force on Measures to Reduce the
Demand for Drugs (1996, 1997) and consequent structural
changes (see Co-ordination of Drug Policy at Section 3.2) in
the co-ordination of drug policy during 1997 a shift occurred in
drug policy approaches.  There is now more emphasis on the
greater involvement of community groups in the structural and
organisational implementation of drug policies.  This is
accompanied by a more holistic intersectoral approach (health,
education, housing, estate management, employment,
recreation, sport, policing, etc.) to the drug problem involving the
co-ordination of drugs programmes and services at local level,
the involvement of communities in the development and delivery
of locally based strategies to reduce the demand for drugs, and
the focusing of actions on tackling the problem in the
communities where it is most severe.
During 1997 a number of statutes were enacted covering a
range of measures to control the use, supply and criminal
activities associated with drugs.  More controls were introduced
in relation to the issuing of licences for the sale of liquor, as well
as licences for public dancing, music and singing (Licensing
(Combating Drug Abuse) Act, 1997).  Other relevant new
legislation includes the Housing (Miscellaneous Provisions) Act,
1997 which allows local authorities to evict individual tenants
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who are engaged in anti-social behaviour; the Bail Act, 1997
which allows the courts the discretion to refuse bail where they
are satisfied that there is a danger of the commission of serious
offences by a person while on bail.  Under the Non-Fatal
Offences Against the Person Act, 1997 it is an offence for a
person to place or abandon a syringe in a manner which injures,
or is likely to injure, or frighten another person.  A Courts
Commission has made recommendat-ions on the setting up of
special courts for persons charged with non-violent offences,
leading to rehabilitation, where appropriate, rather than serving
custodial sentences.
The Government has recently made extra financial resources
available for a Young People’s Facilities and Services Fund, of
£30m over three years, to support a variety of capital and non-
capital projects in disadvantaged areas.  At least £20m will be
targeted at those areas particularly affected by the heroin
problem.  Allocations from the fund will be made by the Cabinet
Committee on Social Inclusion and Drugs and will take account
of the new co-ordinated focus on the needs of disadvantaged
areas, as well as the work of the Local Drugs Task Forces.
The overall drugs problem is now given a higher profile by all
political parties, more resources have been allocated to problem
drug use and there is now greater emphasis on the involvement
of community groups in the formulation of drug policy.  While the
major tenets of drug policy have not changed the changes in
approach have provided the opportunity for better co-operation
between statutory bodies and community groups, whereby
community interests will be better taken into account in official
responses to the prevention and management of serious drug
problems.
29

Epidemiology
Part II

Types and
4.1 Epidemiology
The core information systems used to monitor the drugs
problem and to inform policy making are in the health and law
enforcement areas.
The Drugs Research Division of the Health Research Board
(HRB) operates the National Drug Treatment Reporting System
providing data on treatment given by statutory and voluntary
agencies on a nationwide basis.  This is the best developed of
the indirect indicators of drug misuse in Ireland.  The value of
this data lies in the provision of information on the uptake of
services and a profile of drug users contacting treatment
services over time.  Data on clients receiving treatment for the
first time can indicate changing patterns and trends of problem
drug use.  A feasibility study is underway which should result in
greater coverage in the System of drug users presenting for
treatment, specifically those being treated by general
practitioners in the community and within the prison services.
Other sources which provide information on treated drug
misuse include the National Psychiatric In-patient Reporting
System which is maintained by the Mental Health Section of the
Health Research Board and the Hospital In-Patient Enquiry
System which is run by the Economic and Social Research
Institute.  The central Methadone Treatment List is a register of
all clients receiving methadone.  This information, which is used
to avoid duplication of methadone prescription, is not available
as an information source.
Information on infectious diseases is limited in that ongoing
monitoring of the proportion of drug users and intravenous drug
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users infected by the Hepatitis B or C viruses is not available.   
Data on drug-related mortality are also limited mainly due to
the methodology used to collect this information.  The EMCDDA
is investigating the opportunities for comparing drug-related
mortality data in the different EU countries.  Other aspects of
mortality, such as drug-related car accidents and murders need
to be investigated.  
Law enforcement data are a good reflection of the number of
criminal charges for drug offences.  These data are based on
events rather than individuals - a person could be charged more
than once in a given year.  Seizures of drugs data reflect the
activity of police and customs authorities and could be biased by
the efficiency of detection methods, for example, the number of
personnel involved in the detection of such crimes, the use of
sniffer dogs or the availability of equipment.  The purity of drugs
is analysed by scientists at the Forensic Science Laboratory and
tests are carried out on samples of all products seized, except in
the case of cannabis where tests are carried out on random
samples of seizures.  Information on the price of drug products
is collected by the police at street level.   The quality of the latter
data is difficult to ascertain.
4.2 Indicators of drug misuse
Drug treatment data are collected by the National Drug
Treatment Reporting System (NDTRS) which provides national
coverage on treated drug misuse.  The data are a good
reflection of the number of clients availing of the treatment
services which are provided.  A shortage of resources prevents
a small number of agencies from returning data.  General
practitioners providing treatment to drug users are not as yet
well represented in the system.  Plans to do so are under way,
by way of a feasibility study which should result in greater
coverage of those treated by general practitioners and also
those treated within prison services.  The System provides core
socio-demographic information, problem drug using patterns
and risk behaviour in relation to treated drug misuse.  The
instrument used to collect data is based upon the definitive
protocol formulated by the Pompidou Group of the Council of
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Europe. There is however, a time-lag between initial drug use
and the demand on services for treatment.  Accordingly, the
NDTRS is an indirect indicator of drug misuse and as such it is
limited.  An annual report is published each year.
Hospital psychiatric data are available from the National
Psychiatric In-patient Reporting System (NPIRS).  This
monitoring system collects data on admissions to and
discharges from public and private psychiatric hospitals and
units in Ireland.  It provides information on the activities of the
inpatient psychiatric service (admissions, discharges and
deaths).  An annual report provides information on gender, age,
marital status, socio-economic group, legal status, diagnosis
(ICD-10) and length of stay.   A review of changes over time is
also provided by the system, from computerised data going back
to 1971.
The Hospital In-Patient Enquiry (HIPE) Scheme is a computer
based health information system designed to collect medical
and administrative data regarding discharges from acute
hospitals (excluding private hospitals).  Each discharge record
represents one episode of care and patients may have been
admitted to hospital more than once with the same or different
diagnoses.  These records facilitate analyses of hospital activity
rather than incidence of disease, with information on primary
and secondary diagnoses (ICD-9).
Infectious diseases are required to be notified to the
Department of Health and Children and statistics are published
annually.  Hepatitis B is a notifiable disease but it is generally
accepted that there is under-reporting and that the notification
system is not a good indication of the true incidence of infection.
AIDS data (total cases, number of intravenous drug users -
IVDU, total number of deaths and number of IVDU deaths) are
collected by regional AIDS co-ordinators and returned to the
Department of Health and Children.  HIV data are collected by
the Virus Reference Laboratory and submitted to the
Department of Health and Children.
Mortality data are collected by regional Registrars of Births
and Deaths, from a number of sources (medical practitioners,
police, coroners) and returned centrally to the Registrar
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General’s Office.  These data are reported upon (Report on Vital
Statistics) by the Central Statistics Office (CSO) on behalf of the
Department of Health and Children.  The information from the
CSO is the most complete and comprehensive available.
However, the procedures used at present to collect these data
can result in the loss of information on the fact that a death was
drug-related.  Deaths are classified according to the World
Health Organisation’s ICD-9 (the latest revision ICD-10 is to be
introduced in 1998) where it is the underlying cause of death
which is recorded.  Even though information on the drug-related
aspect of a death is frequently available in the data collection
process, in the absence of a specific methodology to capture
this item it can be lost, thus limiting the data.  The procedures
used in recording a death (specifically in relation to suicide) are
being examined by a task force appointed by the Minister for
Health.  An amendment that would elicit information on whether
a death was drug-related, has been recommended to this
committee.  A report on the work of this group was published
early in 1998(Report of the National Task Force on Suicide).
In the area of law enforcement, national data are collected by
the Garda Síochána and published annually.  For the purpose of
this report arrests data are defined as the number of charges for
drug offences.  Breakdown is given by drug and whether it was
intended for possession or traffic/supply.  The data are event-
based, individuals cannot be identified so the number of
individual persons involved is not known.  
Collection of drug seizures data is carried out by the Gardaí
and the Customs Service.  Information includes the quantity (by
weight) and the number of seizures of illegal drugs as well as
type of drug involved.  These data are inter alia a reflection of
the activity of the police and the Customs authorities.  Methods
of detection, for example the number of personnel involved in
the detection of such crimes, could influence the consistency of
the data over time.
Information on drug product purity is collected by the police
from seizures of drugs.  Analyses are carried out at the Forensic
Science Laboratory of the Department of Justice.  Ad-hoc
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5.1 Drug consumption in the population
In recent years a number of local area schools surveys have
been carried out in Ireland. Morgan and Grube (1994)
conducted a survey among a sample of Dublin youth and while
the emphasis was on drinking among post-primary school
pupils, information was also collected on lifetime prevalence of
drug use (Annex B, Table B1).  The study found that an increase
in drinking was part of a broader phenomenon including higher
levels of usage of a range of other substances including illegal
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Greater Dublin Area.
Lifetime Prevalence of Drug Use
Source: Grube and Morgan, 1994
In 1994 a descriptive survey of substance misuse among
adolescents of school-going age, approximately 12 to 18 years
old was conducted in the Western Health Board area.  The
sample was selected ‘to have as representative a sample of the
school going population as possible’ (Kiernan, 1995).  As there
is evidence that substance misuse is higher among early school
leavers, a sample of this group was also included.  The school
Type of Drug 1991 1984
% %
Marijuana 25.1 13.2
Solvents 18.9 12.9
Cocaine 2.2 1.5
Barbiturates 2.2 2.7
Heroin 1.4 1.2
Amphetamines 2.9 3.3
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years selected were weighted to include more students from the
senior cycle than the junior cycle, so that comparisons could be
made between school-going students and early school leavers.
Lifetime prevalence rates (see Table 5.2) were determined
among the sample as a whole.  Again in this case cannabis and
solvents were the drugs most likely to have been used.
38
Table 5.2
Western Health Board
Lifetime Prevalence of Drug Use
Source: Kiernan, 1995
Type of Drug 1984
%
Cannabis 15.5
Solvents 14.3
‘Magic Mushrooms’ 5.1
LSD 3.7
Ecstasy 2.2
Tranquillisers 2.0
Cough Syrup 6.2
Amphetamines 1.9
Cocaine 1.0
Heroin/Opiates 0.8
Table 5.3
Southern Health Board.
Lifetime and Current Prevalence
of Drug Use
Source: Jackson, 1997 (Interim report)
Preliminary results of two surveys carried out in regional
Health Board areas show that after alcohol and tobacco,
cannabis is the most frequently used drug.  In the Southern
Health Board area a sample of 1500 (aged 15-44) from the
general population was surveyed (Table 5.3).  ‘Current
prevalence’ is defined as use in the past month.
Preliminary results from a study in the North Eastern Health
Board where 1,516 adolescents aged between 13 and 19 years,
from 21 schools in the area were randomly administered a
confidential questionnaire, show that 10 percent had regularly
used cannabis.  Regular use is described as monthly or weekly
use.
In 1995 a nationwide school survey of sixteen year old post-
primary school pupils (European School Survey Project on
Alcohol and Drugs - ESPAD) was carried out in collaboration
Type of Drug 1996 1996
Lifetime Current
% %
Cannabis 17 4
Hallucinogens 6 0.4
Amphetamines 3 na
Ecstasy 3 na
Sedatives 2 0.5
Opiates 1 na
Cocaine 1 na
Crack 0.3 na
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with the Pompidou Group of the Council of Europe and CAN,
Sweden  (Hibell, B. et al., 1997).  This showed a marked
increase, to 37 percent in lifetime prevalence (that is, at any time
in the past) of cannabis use, on the 1991 study mentioned
above.  This is three times the average of the other European
countries involved in the study.  Only one other country, the UK,
was higher at 41 percent.  On closer examination of the
frequency of the use of cannabis among students in Ireland, it
was shown that 7 percent of them had used cannabis more then
ten times in the previous year and a similar proportion (7
percent) had used it more than six times during the previous
month.  The Irish figure for lifetime experience of LSD or other
hallucinogens was 13 percent (UK, 14 percent), for those who
had used any illicit drug other than cannabis it was 16 percent
(in the UK it was 21 percent; the European average was 4
percent) while the percentage who had used tranquillisers or
sedatives without a doctor’s prescription (7 percent) was similar
to the average European figure.  Sixty percent of students in
Ireland stated that they had never used any drug while 33
percent said that the first drug they had used was marijuana or
hashish.  Lifetime experience of ecstasy was 9 percent for Irish
students (8 percent for students in the UK).  It was very clear
from this survey that ecstasy (MDMA) was perceived as very
easy to find in Ireland - 54 percent said that getting this drug was
‘very easy’ or ‘fairly easy’.  Amphetamines were also reported to
be easy to obtain - by one third of students.  When the
perception of risks involved in behaviour such as frequent
alcohol use or drug taking was examined, students in Ireland
had below average perceptions of ‘great risk’ on all the
behaviours in comparison with other European students.  
5.2 Problematic Drug Use
The best available information on the current situation of
problem drug use in Ireland is data from the National Drug
Treatment Reporting System.  This information is collected by
the Drugs Research Division of the Health Research Board and
refers to people who receive treatment for problem drug use.
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Treatment can be medical (detoxification, methadone or drug-
free programmes) or non-medical (addiction counselling,
individual/group therapy or psychotherapy).  From 1990 to 1994,
data was collected in the Greater Dublin area only.  In 1995 the
Reporting System was extended to the whole country.
Problematic opiate use is concentrated mainly in the Dublin area
in localities with high levels of socio-economic deprivation.
While the use of cannabis and ecstasy is reported to be on the
increase throughout the country among young people in
particular, the numbers of people treated for problem opiate use
outside of Dublin remains relatively low.
Opiates were the drugs reported to be causing the most
problems in four out of five of those presenting for treatment in
Dublin over the seven-year period, 1990-1996  (see Annex B,
Tables B2-B7).  While the majority of these injected their stated
primary drug of misuse there was a fall in the proportions over
the seven-year period.  This could perhaps be explained by the
fact that there is an increase in the practice of smoking heroin
among an increasingly young treated population.
5.3 Patterns of use and characteristics of users
There are regional differences in drug use patterns in Ireland
with the use of opiates mainly confined to the Dublin area.  From
schools and youth surveys (see Tables 5.1, 5.2) it is apparent
that the drug experiences of young people in the west of Ireland
are different from those of young people in the east of the
country, with higher lifetime prevalence rates in Dublin.  
Data from the National Drug Treatment Reporting System
also suggest that there is a great disparity in the pattern of drug
use in different parts of the country.  The majority of cases (88
percent) were treated in the Eastern Health Board area (EHB).
The Southern Health Board area (SHB) had the next highest
proportion treated but this was only 6 percent of cases, while 3
percent were treated in the South Eastern Health Board area
(SEHB).  The type of drug used also varied in different areas.  In
the EHB the problems were largely associated with opiate use
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while in the SHB it was cannabis followed closely by ecstasy
use.  Outside of the EHB the most common drug used was
cannabis (Moran et al., 1997).  The characteristics of users
using different types of drugs also varied, for example, whereas
25 and 10 percent of users treated for cannabis and ecstasy use
respectively were still at school, only 1 percent of heroin users
were. 
It is likely that those encountering very serious problems will
eventually present to the treatment services.  Thus the
characteristics of more problematic drug users are represented
by the treated population of drug users.  The profile of the typical
problem drug user who presents for treatment is that of a young,
unemployed male, leaving school at an early age and likely to be
living in a disadvantaged area in Dublin (Annex B, Table B9).
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Route 1990 1991 1992 1993 1994 1995 1996
Inject 48.3 36.2 33.9 44.1 46.7 29.9 31.3
Smoke 27.6 39.4 41.0 32.8 38.6 56.6 60.0
Eat/drink 17.0 16.2 19.4 20.8 13.2 12.0 7.3
Sniff 7.1 8.2 5.7 2.2 1.5 1.4 1.4
Valid N 601 437 661 850 1144 1386 1469
Total N 624 450 668 859 1150 1396 1499
Table 5.4 Dublin.  Route of Administration of Primary Drug.
First Treatment Contacts.  Valid Percentages.  1990 - 1996
Source: Drug Treatment Reporting System, HRB
Table 5.5 Dublin.  Risk Behaviours  First Treatment Contacts.
Valid Percentages.  1990 - 1996
Risk 1990 1991 1992 1993 1994 1995 1996
Ever Injected 59.9 44.2 41.7 50.8 52.5 40.6 40.4
Ever Shared 69.3 55.6 58.6 54.9 37.9 16.5 18.4
Currently injecting 68.0 71.0 76.5 76.8 70.7 25.3 27.4
Currently sharing 17.0 18.5 17.4 14.2 9.7 5.2 7.7
Total N 624 450 668 859 1150 1396 1499
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5.5 Risk and protective factors
While no analytical studies on risk and protective factors for
beginning of drug use have been carried out to date in Ireland it
was found that ‘there seemed to be a direct relationship
between closeness and peer/friend influence in the sense that
the group of age-mates who were psychologically closer to the
individual seemed to have a relatively greater influence’
(Morgan and Grube, 1994:66).  A study, by the same authors,
which aims to identify the key mediating factors that are
responsible for initial experimentation with drugs among young
people, is due to be finished in 1998.  Data from the treated
population of drug users suggest that a high proportion of those
coming into treatment for the first time are male (70 percent) and
that 45 percent were 15 years or younger when they first used a
drug other than alcohol or tobacco (Moran et al., 1997).
5.6 Different drug profiles
Indications from school and youth surveys suggest that, after
alcohol, cannabis is the most commonly used drug.  Anecdotal
evidence suggests that among young people of all social groups
and in all areas of the country, cannabis and ecstasy use is
becoming more prevalent in the club scene.  Again, anecdotal
evidence suggests that middle class users tend to use cannabis,
ecstasy and LSD recreationally.  Ecstasy and LSD are
reportedly associated with the club scene.
Over a number of years the profile of drug users who present
for treatment shows that heroin and morphine sulphate tablets
(MST) were the drugs most commonly used and the main
reason for which clients sought treatment (see Annex B, Table
B10).  Over the seven year period since data collection began in
Dublin, heroin as the primary drug of use has been increasing
with a corresponding decrease in the use of morphine sulphate
tablets.  In 1996 heroin was the main drug for which treatment
was sought in eight out of ten cases.  A breakdown of the
secondary drug of misuse is given at Annex B, Table B11.  The
use of benzodiazepines as part of a wider pattern of drug use
has increased significantly over these years; methadone misuse
is also a cause for concern.  Figures for cannabis use as a
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6.1 Mortality
It is generally accepted that the procedures used at present in
Ireland to collect drug-related mortality data can result in the
loss of information that a death was drug-related, thus limiting
the data.  A detailed examination of the data available from the
Central Statistics Office on deaths recorded with an ‘underlying
cause of drug dependence’ (International Classification of
Diseases Code 304) over a twelve-year period shows that the
majority were male in the age-group 15 to 39 years.  For the 15-
49 year age group the number of deaths went from 14 in 1985
to 3 in 1986 and 1987, to 13 in 1992 and 33 in 1996 (see Annex
B, Table B12).
While information on overall mortality among drug addicts is
not available, data on deaths from AIDS has been collected by
the Department of Health & Children since 1982.  Between 1982
and 1996 approximately half of those who died from AIDS were
intravenous drug users.  In 1997,  there was one intravenous
drug use related death out of a total of seven AIDS deaths (see
Annex B, Table B13).  This shows a considerable drop in the
number of intravenous drug-related AIDS deaths in the past five
years.
6.2 Morbidity 
Intravenous drug users make up the highest risk category of
confirmed cases of AIDS in Ireland.  The figure  was 43 percent
in 1996, and 32 percent in 1997.  This proportion, which has
decreased over the years since recording commenced in the
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mid 1980s, peaked in 1993 at 63 percent (see Annex B, Table
B13).
Because of the regional difference in drug use patterns, with
opiate use mainly confined to the Dublin area, it can be
assumed that drug-related AIDS/HIV prevalence is higher in
Dublin.  Of the samples tested in the Virus Reference Laboratory
for HIV antibodies between 1986 and 1996, a cumulative total of
1,731 samples have tested positive.  Forty six percent of these
(797) were intravenous drug users.  Since individuals may have
been tested more than once, the number of tests does not
necessarily correspond to the number of individuals tested.
A study to quantify the sero-prevalence of antibody to
Hepatitis C virus was carried out among 272 injecting drug users
at the National Drug Treatment Centre, Trinity Court, over a one-
year period (Smyth et al., 1995).  The overall sero-prevalence
was found to be 84 percent, and a significantly greater
proportion of females tested positive than males.  The high
prevalence of Hepatitis C might indicate the sharing of injecting
equipment.  This is not reflected in current trends in the National
Drug Treatment Reporting System data, which show less
injecting/sharing and more smoking of the primary drug of
misuse.  The study results could perhaps be explained by the
small sample size.  However, it could perhaps also be explained
in terms of the reluctance of drug users to admit to injecting and
sharing practices.  Hepatitis B could not be considered to be an
indicator of incidence of drug injecting in Ireland in view of the
fact that a vaccine is offered.
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1990 1991 1992 1993 1994 1995 1996
First Admissions
Number 105 124 145 167 200 66 236
Rate 3.0 3.5 4.1 4.7 5.6 7.5 6.5
Source: National Psychiatric Inpatient Reporting System, Health Research Board
Table 6.1
First Admissions to Irish Psychiatric Hospitals and Units for #
Drug Dependence .
Numbers and Rates per 100,000 population.
Type of Drug 1992 1993 1994 1995 1996
Cannabis 2768 3007 3082 2600 1834
Heroin 91 81 230 296 432
Other Opiates 170 136 - - -
Cocaine 11 15 15 30 42
Amphetamines 49 82 81 138 152
LSD 48 129 119 70 24
Ecstasy 65 135 261 645 340
Other offences 292 248 655 385 454
Total 3494 3833 4443 4164 3278
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Williams et al. (1990) studied the level of depressive
symptomatology reported by a sample of opiate addicts who
were receiving methadone maintenance therapy, and attending
the Drug Treatment Centre, Trinity Court  in Dublin.  A high level
of depressive symptoms were found after completion of the
Black Depression Inventory.  They conclude that the relationship
between depression and opiate dependency in the group
studied ‘is likely to be complex and multifactorial’ and is open to
various interpretations e.g., that opiate use may be a method of
self medication to relieve depressive feelings, or that depressive
symptoms could represent a reaction to problems of living, or
could be explained by familial factors.  However, they go on to
say that ‘ awareness and recognition of depressive symptoms
have an important bearing on the effective treatment of opiate
dependent individuals’.
6.3 Legal Problems
Table 6.2 below shows the number of charges for drug
offences over a number of years.  These data refer to events
and not to individuals, the same person could be prosecuted for
a number of offences in the same year, or for the same offence
a number of times in the same year.  Over the five-year period
the number of charges for cannabis offences has decreased
while prosecutions for heroin offences has increased almost
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Source: Annual Reports of An Garda Síochána.
Table 6.2 
Ireland.  Number of Drug Charges by Type of Drug
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In 1996 cannabis was involved in 63 percent of offences
against the Misuse of Drugs Acts, 1971 and 1984.  Heroin and
ecstasy accounted for 15 and 12 percent respectively.  There
were regional differences in the drug types involved.  Almost all
controlled drug offences involving heroin took place in the Dublin
area where they accounted for over a third of total offences.
Ecstasy proceedings accounted for a fifth of the total in the
southern region (Cork, Kerry and Limerick).  Cannabis offences
constituted the majority in all areas.
A study carried out by the Garda Research Unit looked at the
association between illicit drug use and crime in the Dublin
Metropolitan Area.  The sample was based on all Garda records
of persons arrested, charged or suspected of criminal activity
(Keogh, 1997).  It was found that a majority of people were
involved in crime before becoming involved in drug activities.
Over one third had left school before the official school leaving
age and a majority said that they had a poor understanding of
the effects of drug use.  While three quarters of the respondents
had at some time sought treatment for drug misuse and most
had received it, a number had not sought treatment of any kind.
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7.1 Sources of supply and trafficking
patterns
According to police intelligence the sources of supply vary
according to the type of drug.  While some smaller seizures of
cannabis are known to have originated in Pakistan, Afghanistan
and Lebanon, cannabis comes mainly from Africa.  Asia
(Afghanistan, Pakistan, India, Laos, Thailand) is usually the area
from which heroin seized in Ireland originates.  More recently
Turkey is emerging as a source for heroin.  South America is the
source of the bulk of cocaine seizures.
The police report that most of the trafficking in cannabis takes
place between Morocco and the south coast of Ireland, on sea-
going yachts and articulated trucks using cross-channel ferries.
The bulk of heroin seizures are transported to Ireland through
the UK and some from the Netherlands.  It has come to the
notice of the authorities that middle-aged people, not known to
the police, are being used as drug couriers from Europe.
Quantities are relatively small and specifically for the home
market.  Batches of ecstasy tablets are imported in luggage by
couriers or in vehicles.  There have been quite a number of
seizures of skunk (a term used to describe a potent form of the
cannabis plant) from factories located in for example, an attic,
warehouses and a bathroom, where it is being produced by
means of hydroponics.  Apparently such production is easy to
set up with catalogues and instructions available on the Internet
.  This makes the enforcement of Section 5 of the Misuse of
Drugs Act, 1984 virtually impossible.  ‘Advocacy’ offences, as
they are sometimes refered to, relate to the publication of
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material which appears to advocate or encourage the use of
controlled drugs. 
Police sources believe that not all drugs seized in Ireland are
for the home market particularly in the case of cannabis and
heroin.  It is speculated that Ireland with its long coastline is
used as an access point for transit to UK and Europe.  They also
believe that the distribution of drugs within the country is
organised by networks of criminal gangs.  In some cases these
gangs involve members of the same family.
Sale patterns at street level in Dublin differ from area to area,
with price and purity of drugs varying with demand
requirements.
7.2 Illicit drug market indicators
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Source: Annual Reports of An Garda Síochána.
Table 7.1
Ireland.  Quantity of Seizures by Type of Drug
Type of Drug 1992 1993 1994 1995 1996
Cannabis (kg) 519 4206 1527 15616 1940
Heroin (kg) 0.8 1.3 4.6 6.4 10.8
Cocaine (kg) 9.9 0.4 0.1 21.8 642
Amphetamines (kg) 0.1 0.7 0.4 1.5 7.6
LSD (units) 13431 5522 16634 819 5901
Ecstasy (tablets) 271 744 28671 123699 19244
There were no ecstasy seizures in Ireland until 1991.  Since
then they have increased each year (see Tables 7.1, 7.2) and
very significantly so, in 1995.  The police report that in 1995
there was one seizure in Dublin of 40,000 ecstasy tablets.  In
another instance illegal substances found in two premises in
Dublin suggested to the police that these premises were used in
the manufacture of ecstasy.
The number of seizures of heroin, cocaine and
amphetamines increased considerably in 1996.  This increase
was also reflected in the quantities seized.  However, two large
Chapter 7: Availability and Supply of Drugs
Drug product purity is ascertained from analyses carried out,
on drugs seized by the Gardaí, by scientists at the Forensic
Science Laboratory of the Department of Justice, Equality & Law
Reform.  Purity data are not included in the Annual Reports of
An Garda Síochána.
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Source: Annual Reports of An Garda Síochána.
Table 7.2
Ireland.  Number of Seizures by Type of Drug
Type of Drug 1992 1993 1994 1995 1996
Cannabis 2643 2895 3511 3205 3449
Heroin 91 81 263 209 664
Cocaine 11 15 38 42 93
Amphetamines 49 82 391 89 217
LSD 48 129 116 62 42
Ecstasy 65 135 261 571 405
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Main trends and new developments in drug use and consequences
It would seem, from the available evidence, that drug use in
Ireland is on the increase.
Schools survey data indicate that there has been an increase
in the consumption of drugs, in particular cannabis.
The use of ecstasy and LSD is reported to be on the increase
in the club scene but this is based on anecdotal evidence.
Data from the National Drug Treatment Reporting System
show regional variation in the types of problem drug misuse
treated throughout the country - in the Eastern Health Board
area which includes the capital city, Dublin, the main drugs
misused are opiates while cannabis and/or ecstasy are the main
drugs for which treatment is provided in other health board
areas.
The age profile of drug misusers in the Greater Dublin Area
over the period 1990 -1996 is getting younger, such that the
mode age was 24 years in 1990 but had reduced to 20 years in
1996.
There has been a shift in the risk behaviour of heroin users
with more young people now smoking.
Problematic drug use continues to be associated with social
disadvantage.  
While opiate use is largely confined to Dublin as noted above,
it receives a lot of media coverage and is associated in the
public mind with increasing levels of crime. 
New information needs, gaps, and priorities
for future work
Heretofore, social research into drug use in Ireland has been
mainly descriptive rather than analytical and has tended to be
small scale and localised.  However in 1996 and 1997 several
research projects have been initiated which will help to fill some
of the information gaps which exist at present.
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Summary: Epidemiology of Drug Use
Regular surveys of drug use amongst young people
(community, second and third level education) would be useful
in describing trends among this cohort. 
There is also a need for detailed information at national level
to establish levels of use of drugs.  Sociological and
ethnographic studies in the community would provide an
understanding of the social nature and the processes involved in
drug use which neither agency-based studies nor population
surveys can sufficiently address.  The particular problems
women heroin users experience in trying to access treatment
needs to be investigated.
Recent reports of an escalation of the smoking of heroin
among young adolescents would need to be further examined
and the motivations involved explored.   
Although information does exist in the areas of drug-related
deaths, viral hepatitis, and non-fatal emergencies, this
information is limited and needs to be evaluated and its
collection needs to be more systematic and standardised.
In recent years there has been particularly heightened
concern about drug-related crime in Irish society.  What is not
clear is whether public fears and beliefs reflect reality.  However,
in the absence of research studies and general population
surveys on the social and cultural aspects of drug use and its
consequences, speculation will continue.  Research is needed
into crime associated with illicit drugs, for example, to establish
to what extent there is a link between illicit drugs and crime, and
what impact the importation, sale and consumption of illegal
drugs has on crime.
There is a need for on-going evaluation research in the
implementation of policy in all areas.  Investigation into the
implications of illicit drugs policy on health, on the economy, on
the criminal justice system are needed.  An evaluation of the
effectiveness of prevention programmes, rehabilitation
programmes, the outcomes of treatment and methadone
maintenance programmes needs to be conducted.  The impact
of media campaigns needs to be assessed.  The Advisory
51

Demand
Part III

Specific
The operational concept the European Monitoring Centre for
Drugs and Drug Addiction has adopted for demand reduction
“comprises interventions which are aimed at decreasing the
demand for drugs at an individual or at a collective level.
Interventions aimed at reducing the harmful consequences
of drug use are also included.  The scope of demand
reduction intervention is wide and consists of many facets.
At one end of the continuum, preventive action aims at not
letting a demand for drugs arise at all, having a wide range
of diverse actions targeted at large groups, e.g.  school
programmes, mass media programmes and community
based programmes.  At the other end are measures of a
limited scope directed at individual drug users, e.g.
outreach work, treatment, prevention of HIV infection and
AIDS.  Generally, each action leading to a drug user
refraining from drug use at a certain point in time, or
refraining from especially harmful practices involved in drug
use is comprised by the operational concept of demand
reduction.” 
(European Monitoring Centre for Drugs and Drug Addiction, 1996)
8.1 First childhood intervention
Intervention, in the form of health education to at-risk groups, is
undertaken as part of the general services provided by maternity
hospitals.
In Ireland the statutory age for starting school is five years, but
in fact most children start school at four years of age.  There are
some official pre-schools but these are not widespread.  There
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are no official drug prevention programmes at the pre-school
level.  However, as part of the overall programme initiated by the
Department of Education and Science to target disadvantaged
areas, a pre-school general education programme has been
initiated in approximately thirty-eight centres.  This is referred to
as the Early Start Programme for the under four-year age-group
and involves parents as well as children.  This is a pilot
programme, it does not as yet have drug prevention aspects but
this could change as it develops.
8.2 School programmes
It should be pointed out that drug education is not a mandatory
item in the curriculum of any schools in Ireland.  At a policy level
there has been an interest in the possibility of doing preventive
work in schools since the late 1960s.  The Working Party on
Drug Abuse (1971) dealt with the topic as part of its terms of
reference, and this was followed in 1974 by the Committee on
Drug Education which in turn gave rise to the Health Education
Bureau.  The Health Education Bureau produced many general
and specific educational packs and did a lot of teacher training
in the area between 1977 and its closure in 1987 (Butler, 1994).
In 1994, the Department of Education and Science in
collaboration with the Department of Health and Children
introduced a substance misuse prevention programme, ‘On My
Own Two Feet’ in second level schools.  ‘On My Own Two Feet’,
was developed by the Health Promotion Unit of the Department
of Health and the Psychological Services of the Department of
Education, in association with the Mater Dei Counselling Centre
and supported by the European Commission.  The resource
materials aim to develop attitudes, interpersonal skills and
knowledge which enable young people to lead healthy lives
without reliance on or misuse of  drugs.  The materials are
particularly designed for a school’s social, personal and health
education programmes, but are also suitable for young people
aged 12 to 18 years in a variety of settings.  The rationale and
effectiveness of the programme have been evaluated by an
external researcher (Morgan et al., 1996).
A similar programme for primary schools was developed
56
Chapter 8: Specific Demand Reduction Intervention Areas
during 1996 and was piloted during the 1996/1997 school year.
At present it is referred to as the Primary Substance Abuse
Programme.  It is a draft resource material for all classes in
primary schools from infants (4-5 year olds) up to twelve year
olds, aiming for a developmental programme starting with a
safety-first approach for infants.  Three clusters of schools, in
Dublin, Cork and Donegal covering both urban and rural areas,
took part in the pilot phase of the programme.  Based on
feedback from the pilot phase the scope of the project has been
widened and the resource materials revised for use during the
1997/1998 school year.  The programme was offered to all
primary schools for implementation on a voluntary basis in the
thirteen areas identified as being worst affected by the drugs
problem and where Local Drugs Task Forces are in operation.  A
programme of in-service training is provided for teachers,
comprising a thirty-hour course.  The courses are offered
through local Education Centres.  A major revision of the
programme is to be undertaken starting with a process and
outcome evaluation study.  This work will be carried out by an
external researcher at the beginning of 1998 and will be followed
by a revision of materials in Summer 1998.
A third schools programme in the health/education area
where drug demand reduction activities are relevant is the
Health Promoting Schools Network.  This is a European network
based on criteria laid down by the Council of Europe, the
European Union and the World Health Organisation whereby
the Departments of Health & Children and Education & Science
collaborate to promote health in the school setting.  It is a
combination of health education and other measures that a
school takes to protect and improve the health of young people
in school.  
The Garda Schools Programme which has been in operation
since 1990 aims to teach children sensible and responsible
patterns of behaviour in order to lessen the risks faced by them;
to be safer on the road and at home; to contribute positively
towards crime prevention; to know the role of the police and to
develop positive attitudes towards the police and the job they
do.  The programme is delivered by way of talks and lectures to
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fifth class pupils (11 year olds) in primary schools.  Resource
materials include a Schools Programme Manual which was
updated to be available in 1997.  Over 1,000 Gardaí are trained
to present the programme nation-wide.
An educational video entitled My Best Friend has been
developed by the Health Promotion Unit of the Department of
Health and Children as an education resource for use in
disadvantaged settings where exposure to drug misuse
presents a serious threat to the health and well-being of young
people.  It seeks to be a trigger for discussion and to give an
insight into the way drug misuse impacts on relationships and
lives.
8.3 Youth programmes outside schools
The National Youth Health Programme is a partnership between
the National Youth Council of Ireland, the Health Promotion Unit
of the Department of Health & Children and the Youth Affairs
Section of the Department of Education & Science.  The aim of
the programme is to develop health education resources and
provide training on health issues specific to young people.  This
includes drug education and prevention.  In 1992 this
programme developed a Solvent Abuse Materials pack which
was designed for use by youth leaders, instructors of community
training workshops, youthreach projects as well as the formal
education sector.  The underlying philosophy is that drug and
alcohol education is not only about drugs and alcohol but also
about people.  Thus, while young people need accurate
information about drugs, this alone is not sufficient to ensure
responsible behaviour.   Information must be backed up by
assistance in the development of skills in relation to the use of
drugs.  This incorporates the enhancement of self-esteem and
decision-making skills.   Young people need to examine
attitudes to drug use, both their own as individuals and the
attitude of the community in which they live.  The programme
pack for the ‘On My Own Two Feet’ programme (described at
Section 8.2) is available to experienced youth leaders with the
expertise to deliver the programme and to workers with
expertise in the area of group work.  The educational video
entitled My Best Friend also provides resource material for youth
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programmes outside schools.
The Drugs Awareness Programme (see Section 8.18) is
provided by the police to various groups and communities
throughout the country.  The Garda Mobile Anti-Drugs Unit
travels the country promoting a drug free lifestyle among young
people.  It is present at major public events and concerts where
young people tend to congregate.  It operates in 23 Garda
Districts throughout the country.
8.4 Mass media campaigns
During 1997 a media campaign was run by the Department of
Health and Children. This was the third phase of the campaign
which took place during the summer and autumn 1996.  The aim
of the campaign is to alert, remind and warn people of the
dangers of drug misuse.  There are two target audiences for this
campaign: 
• 15-25 year olds who are experimenting with drugs or who are
at risk of becoming drug misusers
• parents of young people
The message is ‘drugs destroy lives, not just of users but
people close to them too’.  The television campaign is supported
by cinema and fly posters.  There is a radio element which is
aimed more specifically at parents, urging them to seek advice
if they believe their children are involved in drugs.  It contains
specific messages about ecstasy and heroin.  
The campaign initially included a telephone information line
from which more detailed information was provided.  A
permanent telephone information line is now provided by the
Eastern Health Board.  An anti-heroin poster campaign was
conducted in the Eastern Health Board area using awareness
messages about heroin and ecstasy.  A conference which
specifically looked at ecstasy use was organised by the Eastern
Health Board in November 1997.
8.5 Telephone helplines
A free telephone helpline was provided by the Eastern Health
Board during 1997 and is available five days per week from
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10.00am to 5.00pm.  It was established to provide a confidential
service offering information, support, guidance and referral for
those concerned with any aspect of drug misuse.  A telephone
helpline to the Drug Treatment Centre, Trinity Court is available.
The Southern Health Board also provides a helpline offering
information on prevention and service provision.  This is a free
telephone service.  The South Eastern Health Board funds a
non-governmental organisation called Waterford Drug Abuse
Resource Group, to provide a helpline in the area.  Narcotics
Anonymous provides a telephone helpline.
8.6 Community programmes
The Inner City Organisations Network (ICON) is an umbrella
organisation which aims to link up voluntary and community
groups operating in the north-east inner city of Dublin.  As a local
network, ICON aims to promote ‘partnership’ between state,
non-state, business and community groups in the area.  During
1997 ICON continued the Drugs Crisis Campaign, the Inter
Agency Drugs Project and the Integrated Education and Family
Support Initiative.  These projects are concerned with
developing integrated locally based responses in relation to
drugs in the areas of treatment, education, prevention and
rehabilitation.  The overall aim is to develop coherent policies
and strategies which can be implemented at a local level while
taking into account the particular needs of the north-east inner
city.
The Inter-Agency Drugs Project (IADP) is a lobby group
based in the north inner city of Dublin and is made up of three
sub-committees:- educational and prevention; treatment and
rehabilitation; and supply/control.  It acts as a forum for inter-
agency interaction and has made significant inputs to the
development of drugs policy, e.g. legislation concerning housing
and the Criminal Assets Bureau.  This project was evaluated in
1997 as the nominated Irish programme for a WHO Study -
Multi-City Action Programme on Drugs.  A report will be
published in 1998.  
On the south side of Dublin city similar organisations also
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exist.  The South Inner City Treatment Services Group, which
works closely with statutory bodies, is an organisation consisting
of voluntary and community groups of people who either live or
work in the south inner city area of Dublin.  Their aims include
developing and devising practical and effective means of
tackling the local drug problem.  The programme includes
promoting education and training, research and evaluation, and
networking with other community groups.
Drug Questions - Local Answers is a community-based
training programme for health/education professionals, Gardaí
and youth workers.  The Health Promotion Unit of the
Department of Health and Children has provided convenor
training programmes in conjunction with the eight regional
health boards.  
Employment - Youthstart is an EU programme for 18 - 25 year
olds which provides integrated education, training and work
experience for early school leavers.  The programme works in
conjunction with the Member States by supporting transnational,
innovative pilot actions.
Urrús (Gaelic for strength/confidence) was founded by a
community group, the Ballymun Youth Action Project, to provide
training for trainers.  The aim is ‘to establish a centre of learning
and excellence where people can access a range of training
options aimed at increasing their effectiveness in the area of
responses to drug misuse’ (Urrús flyer).  This community
addiction studies training centre has developed a range of
training modules on drug misuse, addiction and community
responses to meet individual agencies’ needs comprising Short
Workshops, Training for Trainers and Community Addiction
Studies Course.  Topics covered include information about
drugs, the addiction process, signs and symptoms, intervention,
developing a club policy, family issues and community
development approaches.  A number of target groups has been
identified.  They include members of the community, community
workers, doctors, police, probation officers, teachers, nurses,
school guidance counsellors, junior liaison officers, FAS
workshop tutors, Youthreach tutors and prison workers.  The
project is supported by the EU human resources initiative, the
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Horizon Programme and the Eastern Health Board.
Ad-hoc community based activities targeted at local drug
users and suppliers, are organised in areas where open drug
using and dealing are prominent.
8.7 Outreach work 
Outreach work is an integral part of the drug services provided
by the Eastern Health Board.  It  aims at one-to-one contact with
drug users who are not in touch with treatment services and
offers advice to untreated drug users and also health care by
referring users to treatment agencies if they so wish.  
8.8 Low threshold services
A Mobile Clinic was established in the Eastern Health Board in
1996.  The service is low-threshold (minimal service provision)
and provides services, such as needle exchange and low
dosage methadone, to the more chaotic drug user who is
addicted to an opiate, is injecting and is incapable of
stabilisation on methadone maintenance.  It initially served two
locations in the inner city of Dublin.  During 1997 the service was
provided at a third location in the north of the city.  
8.9 Substitution/Maintenance programmes 
As opiate use was relatively rare in Dublin until 1979/1980
methadone treatment was used primarily for detoxification
purposes until the 1980s, the main exception being pregnant
women and women in the period immediately after childbirth.
However, in the late 1980s following the identification of the link
between needle sharing and HIV transmisssion methadone
maintenance programmes were gradually introduced.  This new
policy was confirmed by the Government Strategy to Prevent
Drug Misuse (1991) and later the First Report of the Ministerial
Task Force on Measures to Reduce the Demand for Drugs
(1996) reaffirmed this policy stance and recommended
measures to reduce waiting lists for methadone maintenance.
The services were decentralised and made available on a more
widespread basis in local areas of Dublin.  On contact with the
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service each person is assessed individually and treatment can
be one of several options, short-term methadone treatment with
a view to detoxification or more long-term maintenance in the
case of more problematic opiate users.  Maintenance
programmes form part of the drug services provided by the
Eastern Health Board.
8.10 Prevention of HIV infection among
drug users
All the main treatment programmes involve counselling and
advice to drug users, aimed at avoiding transmission of HIV
particularly by the promotion of safe injecting practices.  The
intravenous use of drugs is discouraged and where this is not
possible needle and syringe exchange programmes, as well as
advice on safer sex practice are provided.  Screening for HIV,
Hepatitis B and Hepatitis C also forms part of drugs services.  
8.11 Treatment systems
Treatment is defined for the purpose of the National Drug
Treatment Reporting System in Ireland as any activity which is
targeted directly at people who have problems with their drug
use, and which aims to ameliorate the psychological, medical or
social state of individuals who seek help for their drug problems.
Thus, treatment can be medical or non-medical.
In most cases treatment for dependent opiate use is given on
a non-residential basis.  This is in keeping with the concept of
community care, pioneered in the area of mental health.  The
social ideology underlying the community approach being that
people remain in their own community, living independent lives
with responsibility for themselves. 
Over four thousand persons in Ireland (mainly in Dublin)
receive treatment at non-residential agencies.  These can be
specialised centres, low threshold agencies, substitution
programmes or units based in the general services.
The treatment strategies adopted by detoxification services,
mainly in the Eastern Health Board area are as follows: 
• methadone detoxification programmes
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• methadone maintenance programmes 
• lofexidine treatment
• drug free programmes.
Methadone maintenance makes up the highest proportion
and lofexidine treatment the least.  The present policy, which is
still developing, is that stabilised drug users after initial treatment
at treatment centres would move on to treatment by general
practitioners in the primary care setting in their own
communities. 
8.12 Detoxification
Detoxification and the control of withdrawal and craving
symptoms of opiate dependent drug users forms part of the
service of all specialised medical drug treatment services   (cf.
Section 8.11).
8.13 Non-residential treatment
In the majority of cases treatment for problems associated with
problem drug use is provided in a non-residential setting (cf.
Section 8.11).
8.14 Residential treatment
Dependent opiate use is not generally treated at inpatient
hospital level in Ireland.  It is only in acute cases that clients are
admitted to hospital.  A number of beds is allocated for
detoxification in the hospital setting.  Approximately 130 places
are available in Ireland in specialised residential centres
(statutory and voluntary), including detoxification units in
hospitals.
8.15 After-care
Treatment and rehabilitation services in Ireland have
traditionally recognised the importance of after-care
programmes.  Coolmine Therapeutic Community has always
had a phased stage as part of its general programme to
gradually reintroduce its clients to ordinary community life and in
recent times it has emphasised the importance of educational
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and vocational training for drug users who hope to remain drug
free and be fully integrated into the life of the community.
Similarly the Ana Liffey Project and the Merchants Quay Project
have developed a range of such training initiatives.  
Soilse is an Eastern Health Board dedicated drug
rehabilitation programme specialising in insertion to
employment, vocational training and education.  Soilse aims to
overcome the limitations of a narrow psycho-therapeutic
approach to addiction by building goals and supporting
participants in their desire to re-socialise themselves personally,
economically and culturally.  Soilse seeks to re-integrate former
drug users into society through restoring independence, self
esteem and self direction.  The programme is a non-residential
day drug rehabilitation model, balancing group therapy and
counselling (resistance training and normative education) with
creativity and soft vocation skills.  The programme has two
group types - a part-time programme which runs for eight weeks
and is designed for those who are undergoing detoxification and
to assess the suitability, stability and motivation of the individual;
a full-time programme which runs for six months duration, where
each participant is paid a training allowance to attend, with a bus
pass and a crèche allowance provided where necessary.
Soilse provides an on-site careers guidance/mediation
service to current and past full-time participants.  The focus is on
realistic goal setting, planning and problem solving, presentation
skills, and through mediation and life planning placing
individuals in employment and vocational training and
education.  The project provides a wide range of inputs for the
course participants.  Group therapy is available each week,
individual work is on-going and lectures and information on
addiction are given weekly.  Soft vocational skills-based learning
such as, literacy, information technology, creative writing,
photography, personal development, drama and art, are
provided.  Weekly workshops are organised to deal with a
diverse range of needs-based issues such as financial advice,
diet, exercise, health, family law, alternative therapies and stress
management.  
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8.16 Self-help groups
Narcotics Anonymous is a self-help support group for drug users
who are trying to stop using drugs.  Nar Anon is a fellowship of
men and women whose lives have been or are being affected by
another person’s drug taking.
8.17 General health care
In addition to the services of specialised centres for the
treatment of drug use, clients may also avail of the services of
the general health care system, for example, general
practitioners, accident and emergency services, STD (sexually
transmitted diseases) clinics and, in certain cases, pharmacies
for prescribed drugs.  
8.18 Criminal justice system
The Juvenile Diversion Programme was established by the
Garda Síochána to provide the opportunity to divert juvenile
offenders from criminal activity and also to provide an alternative
to their being processed through the formal criminal justice
system.  The aim of the programme is crime prevention through
education and rehabilitation.  It gives the opportunity to divert
juvenile offenders from criminal activity.  The programme
currently operates on an administrative basis.  The Children Bill,
1996 proposes that it would operate on a statutory basis.  A
juvenile offender who is eligible for inclusion in the programme
is dealt with by way of a caution, which may on a formal or
informal basis, as opposed to being prosecuted for a criminal
offence.  This programme comes under the supervision and
direction of the Garda National Juvenile Office throughout all
Garda divisions in the country and is operated by the Juvenile
Liaison Officer scheme which was set up in 1963.  Juvenile
Liaison Officers are involved in all aspects of youth work both
locally and in some cases nationally, through contact with youth
clubs, statutory and voluntary organisations and schools.  This
involvement is aimed at dealing with young people on a
personal level and in conjunction with the family and the
community.  All Juvenile Liaison Officers complete a substance
misuse course at the Garda Training College in Templemore.
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The training for this course was co-ordinated by the Department
of Social Studies at Trinity College.
The Drugs Awareness Programme is a programme provided
by the Gardaí to various groups and communities throughout the
country.  The aims of the programme are to create a rapport with
parents, teachers, community leaders and other concerned
groups; to assist young people already exposed to drugs and
give them the confidence to refuse them; to promote responsible
attitudes and to reduce crime.  A ‘Drugs Awareness’ pack is
issued through Garda Divisional Offices around the country.
Drug treatment services, including a methadone treatment
programme, in the main prison (Mountjoy) in Dublin are currently
provided under the supervision of a consultant psychiatrist.  One
of the main recommendations of the Second Report of the
Ministerial Task Force on Measures to Reduce the Demand for
Drugs (1997) was that a study of service provision by way of an
independent assessment by an Expert Group should be carried
out.  This group, which should be made up of an independent
chairperson and two international experts along with the Director
of Prison Medical Services, should examine the effectiveness of
current support for offenders who misuse drugs and make
appropriate recommendations to integrate services both inside
and outside the prison more effectively.
The Probation and Welfare Service of the Department of
Justice, Equality and Law Reform carries out groupwork
programmes, particularly in Mountjoy Prison in Dublin.  These
programmes seek to introduce drug misusers to ideas and
information in order to promote desired behavioural changes in
terms of risk behaviour and drug addiction, and to help prisoners
cope with imprisonment and to prepare them for life demands
following release from prison (Pugh, 1995).  
Voluntary agencies such as the Ana Liffey Project, Coolmine
Therapeutic Community and Merchant’s Quay Project provide
support and counselling to drug users in prison.
8.19 Gender-specific issues
The SAOL programme is an example of a project which seeks
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to deal with gender-specific issues.  It is inner city rehabilitation
and training project for a small group of women in recovery or
stabilised on methadone.  It offers women a chance to acquire a
range of skills including literacy and numeracy and other social
skills in order to give them a better opportunity to return to
normal living.  The Project’s mission statement is:
The SAOL Project is a two year pilot programme for former
and stable women drug users whose purpose is to move
through development work and capacity building from
addiction and dependency to self direction and self reliance.
It operates on the basis of social justice, adult education and
community development principles, and focuses on re-
integration into the community.
The objectives of the project are aimed at three levels,
personal, community and policy:
Personal
• to provide a process where women can gain normality and
stability in their lives
• to provide accredited second-chance education, literacy,
development and training through an adult education and
training experience
• to re-integrate women into their own families and the broader
community
• to raise self esteem and confidence
• to provide a process of education whereby women can
recognise how addiction works
• to prepare the women for life after SAOL
Community
• to educate the women to take an active role in their
community
• to impact through the programme directly on the lives of the
participants’ children, families, neighbours and community
Policy
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• to draw together an integrated response which meets the
holistic needs of the women
• to inform long-term policy on drug treatment and rehabilitation
• to develop an advocacy role on behalf of the women that
ensures the real inclusion of their voices in developing social
and economic policies and practices at  local, national and
European level
• to demonstrate a model for social rehabilitation and access
and provide a methodology for this
• to provide a manual of good employment practice.
The Project gives women from the north inner city area of
Dublin the opportunity to explore their potential through a
participative style of learning that incorporates a community
development approach to the work.  It focuses on using the self
esteem and confidence of participants through development and
education.  In addition, a very important element of the project
has been the type and level of personal support given by the
staff to the women.  The women are encouraged to have a
sense of ownership around the project and are encouraged to
become involved in regular reviews of course design, delivery
and management.  The Project is designed to be flexible enough
to meet the changing needs of the women and structured
enough to ensure that the learning does not become
unfocussed.  
An initial needs-assessment with the participating women
allowed SAOL to develop a framework of activities covering
training, education and development.  The aim of these
particular modules is to enhance existing skills, to expose the
women to new experiences and educational opportunities and to
enable them to make informed choices about their lives. 
Coolmine Therapeutic Community provides a special
programme for women as part of their service.  
8.20 Children of drug users
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Evaluation,
9.1 Evaluation
To date the number of evaluation studies in relation to demand
reduction activities has been limited but there are indications
that public and voluntary bodies are focusing greater attention
on evaluation.
An educational approach to prevention and demand reduction
which was undertaken in post primary schools in Ireland
(Psychological Service et al., 1994) was studied to assess its
efficacy.  The aim of the programme ‘On My Own Two Feet’ is to
prevent the misuse of substances and to help young people to
develop attitudes and behaviours which promote healthy living.
An evaluation of the rationale and effectiveness of this
programme was carried out and published in 1996 (Morgan et
al., 1996).  A central part of the evaluation involved a
comparison of the pilot schools and matched control schools
using a stringent quantitative approach.  The evaluation of the
programme outcomes ‘showed that in comparison to a control
group, children who experienced the programme had less
positive attitudes to substance use and stronger beliefs in the
negative outcomes of such use’ (ibid.: 24).  However, while the
programme had a significant effect on aspects of belief and
attitudes relevant to substance use, the effects on behaviour
were much less, confirming the difficulties involved in school-
based prevention programmes.
A major revision of the Substance Abuse Programme in
primary schools is to be undertaken starting with a process and
outcome evaluation study.  This work will be carried out by an
external researcher at the beginning of 1998 and will be followed
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by a revision of the programme materials in Summer 1998.
A preliminary evaluation study was carried out on the Family
Communication and Self Esteem programme (cf. Section 8.21)
and concluded that the parents involved had understood and
accepted the significance of the link between family
communication and drug misuse perception.  A further
evaluation of the programme is planned. 
A review of drug services in the Eastern Health Board area
was undertaken in order to examine the evolution of policies and
practices in relation to service provision (Farrell and Buning,
1996).  It also took account of service responses from agencies
other than the Eastern Health Board, involving mechanisms for
consultation with local community interests.  The review
commented on service responses in the context of trends and
practices elsewhere.  The report stated that the Eastern Health
Board ‘has achieved an impressive range of goals to date with
the establishment of a network of services and a rapid growth in
its overall size of service provision...  The range and pattern of
service provision is consistent with most and further advanced
than many other European Union member states’ (p2).
Recommendations were made in several areas such as service
provision, training, liaison, and community consultation for the
provision of a more cohesive service.
Evaluation work will also be carried out on the activities of the
National Drug Strategy Team, the Local Drug Task Forces and
the projects of the Local Drug Task Forces.
9.2 Training
Some of the Regional Health Boards provide drugs training
opportunities through their education or related offices to a
variety of groups and individuals.
Training in demand reduction issues is provided as in-service
training by the Department of Education and Science to
teachers who participate in the schools programme (cf. Section
8.2 ).
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A university course (Diploma in Addiction Studies) is
organised at the University of Dublin, Trinity College, to provide
a broad educational experience on issues which arise in the
context of drug and alcohol problems and to accept and
understand the complexities and ambiguities involved rather
than seek simple solutions. During 1997 this Addiction Studies
Course, which is funded by the Department of Health and
Children, was provided with additional funding to double the
number of students in the academic year 1997/1998.   
The Department of Social Studies, Trinity College has
developed a postgraduate Masters Degree Course in Drug and
Alcohol Policy.  This course will commence in September 1998
at Trinity College.
The Irish Association of Alcohol and Addiction Counsellors
(IAAAC) is planning to provide special training modules for its
members.  The course will take place on one day per week over
a two-year period.
9.3 Information requirements
Data collection on demand reduction projects and activities to
date has not been systematic or structured. However, Regional
Health Boards are now collecting information on demand
reduction activities and it is envisaged that this information will
be documented in regional databases. 
In 1997 initial steps were taken by the Focal Point in the
development of a monitoring system on demand reduction
activities in Ireland.  This is in collaboration with the European
Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
where an electronic database has been developed.  This system
which is referred to as EDDRA (Exchange on Drug Demand
Reduction Action), will consist of information collected by each
National REITOX Focal Point on a broad range of demand
reduction activities and will focus on a practical exchange of
experience and good practice in the field.  EDDRA is a long-term
on-going process aiming to cater for the needs of practitioners,
policy and decision makers involved in the planning and
implementation of demand reduction initiatives.   This general
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• The scope of demand reduction intervention is wide and
consists of many facets.  At one end of the continuum,
preventive action aims at not letting a demand for drugs arise
at all, having a wide range of diverse actions targeted at large
groups, for example, school programmes, mass media
campaigns and community based programmes.  At the other
end are measures of a limited scope directed at individual
drug users, for example, outreach work, treatment, prevention
of HIV infection and AIDS.  There has been extensive
development in demand reduction activities in Ireland in
recent years, in particular in the Eastern Health Board area.
• Education and training in demand reduction issues is provided
at a number of levels in the health and education areas. 
• Initial steps in the development of a monitoring system on
demand reduction activities in Ireland got underway in 1997.
• While some evaluation studies in relation to demand reduction
activities have been carried out in recent times there is still a
need for the systematic collection of information along with
scientific process/outcome evaluation of demand reduction
projects.
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Table A2:  Ireland.  Census of Population 1996
Age Group
Source: Central Statistics Office.
Male Female Total %
0-4 years 128740 121654 250394 6.9
5-9 years 145335 137608 282943 7.8
10-14 years 167377 158710 326087 9.0
15-19 years 173950 165586 339536 9.4
20-24 years 149143 144211 293354 8.1
25-29 years 129363 129682 259045 7.1
30-34 years 127735 133194 260929 7.2
35-39 years 126140 129536 255676 7.1
40-44 years 120064 120377 240441 6.6
45-49 years 113816 111584 225400 6.2
50-54 years 94818 91829 186647 5.1
55-59 years 77809 75998 153807 4.2
60-64 years 68690 69256 137946 3.8
65-69 years 60256 66553 126809 3.5
70-74 years 50124 62418 112542 3.1
75-79 years 35228 48869 84097 2.3
80-84 years 21074 34697 55771 1.5
85 years & over 10570 24093 34663 1.0
Total 1800232 1825855 3626087 100.0

Annex B
12-18 year olds. A random sample of schools
and cluster sample of students (2576). 
A sample of early school-leavers from training
centres & community projects (211)
(1) 17
(2) 4
Survey Name
84
Drinking among
Pupils in Post 
Primary Schools 
no.164
1984
&
1991
Longitudinal
School
12-18 year olds. Stratified random sample of
schools from the official Department of
Education list of post-primary schools
1983
valid 100%
1984
(1) 13.2
(2) 5.9
1991
(1) 25.1
(2) 9.2
Report on
Substance Use Among
Adolescents in the
Western Health Board
1994 School 2787valid 100% (1) 15.5
The 1995 ESPAD Report 1995 School
Stratified random number of classes. Three types
of schools: single-sex secondary, mixed
secondary, vocational and community schools.
A total number of 100 classes in the fifth grade
was drawn proportionate to the number of classes 
in each school type - in all 1849 students.
1849
Smoking, Alcohol
and Drug Use
Survey 1996 
in Southern Health Board
1996 GeneralPolulation Random sample of 15 - 44 year olds 1500 _
Report on Illicit Drug Use
among Adolescents in
the North Eastern Health 
Board region
1997 School 15 - 19 year olds.Random sample of 21 schools 1516 _ (2) 10
Year
of
Survey
Type
of
Survey
Sample SampleSize
Response
Rate
Prevalence Rate of
Cannabis Use
Lifetime (1), Current (2)
Table B1: Ireland.  Surveys.  Smoking, Alcohol and Drug Use.
49.6
1.1
0.7
5.3
2.7
6.4
33.3
0.9
Table B3: Dublin
Treated Drug Misuse 1991
Table B2: Dublin
Treated Drug Misuse 1990
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No. of treatment demands
Mean age
Age (%) <25>35
Male/Female (%) 74/26 75/25
IV route of ad. main drug (%)
Primary Drug %
Opiates
Cocaine
Amphetamines
Hypnotics/Sedatives
Hallucinogens
Volatile Inhalants
Cannabis
Other/Missing
79.2
0.8
0.3
3.6
0.4
2.4
11.4
1.8
60.3
1.1
0.5
5.8
0.8
4.6
25.0
1.9
68 48
49
6
69
6
25.0 22.8
All Treatments First Treatments
M F Total M F Total
1501 563 2037 466 158 624
Source: Drug Treatment Reporting System.  Health Research Board
No. of treatment demands
Mean age
Age (%) <25>35
Male/Female (%) 77/23 81/19
IV route of ad. main drug (%)
Primary Drug %
Opiates
Cocaine
Amphetamines
Hypnotics/Sedatives
Hallucinogens
Volatile Inhalants
Cannabis
Others/Missing
77.7
0.4
0.4
4.3
1.0
2.1
12.5
1.7
64 36
45
8
75
4
25.0 21.9
All Treatments First Treatments
M F Total M F Total
1806 546 2359 363 87 450
Source: Drug Treatment Reporting System.  Health Research Board
Table B4: Dublin
Treated Drug Misuse 1992
Table B5: Dublin
Treated Drug Misuse 1993
No. of treatment demands
Mean age
Age (%) <25>35
Male/Female (%) 76/24 79/21
IV route of ad. main drug (%)
Primary Drug %
Opiates
Cocaine
Amphetamines
Hypnotics/Sedatives
Hallucinogens
Volatile Inhalants
Cannabis
Others/Missing
75.1
0.5
0.4
3.6
3.4
2..3
14.0
0.8
48.5
0.6
0.1
4.5
8.2
5.4
31.0
1.6
61 34
48
8
78
4
25.0 21.5
All Treatments First Treatments
M F Total M F Total
1940 599 2555 527 138 668
Source: Drug Treatment Reporting System.  Health Research Board
No. of treatment demands
Mean age
Age (%) <25>35
Male/Female (%) 76/24 80/20
IV route of ad. main drug (%)
Primary Drug %
Opiates
Cocaine
Amphetamines
Hypnotics/Sedatives
Hallucinogens
Volatile Inhalants
Cannabis
Others/Missing
79.1
0.2
0.5
2.6
5.2
1.1
10.3
1.0
64.1
0.3
0.7
2.6
11.4
1.6
18.5
0.7
63 44
56
7
81
3
23.0 21.1
All Treatments First Treatments
M F Total M F Total
2211 695 2919 682 175 859
Source: Drug Treatment Reporting System.  Health Research Board
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Table B7: Dublin
Treated Drug Misuse 1995
Table B6: Dublin
Treated Drug Misuse 1994
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No. of treatment demands
Mean age
Age (%) <25>35
Male/Female (%) 79/21 84/16
IV route of ad. main drug (%)
Primary Drug %
Opiates
Cocaine
Amphetamines
Hypnotics/Sedatives
Hallucinogens
Volatile Inhalants
Cannabis
Others/Missing
82.1
0.3
0.5
1.7
4.2
0.8
10.0
0.4
74.3
0.3
0.5
1.0
6.0
1.1
16.3
0.4
61 47
61
7
84
2
23.8 20.6
All Treatments First Treatments
M F Total M F Total
2342 612 2978 954 188 1150
Source: Drug Treatment Reporting System.  Health Research Board
No. of treatment demands
Mean age
Age (%) <25>35
Male/Female (%) 78/22 79/21
IV route of ad. main drug (%)
Primary Drug %
Opiates
Cocaine
Amphetamines
Hypnotics/Sedatives
Hallucinogens
Volatile Inhalants
Cannabis
Others/Missing
86.8
0.3
0.2
1.8
0.8
0.4
6.6
3.1
77.2
0.4
0.4
1.1
1.1
0.7
12.5
6.6
53 30
64
6
84
2
23.6 20.7
All Treatments First Treatments
M F Total M F Total
2785 787 3593 1092 297 1396
Source: National Drug Treatment Reporting System.  Health Research Board
Table B8a : Ireland
Treated Drug Misuse 1996
Table B8: Ireland
Treated Drug Misuse 1995
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No. of treatment demands
Mean age
Age (%) <25>35
Male/Female (%) 79/21 78/20
IV route of ad. main drug (%)
Primary Drug %
Opiates
Cocaine
Amphetamines
Hypnotics/Sedatives
Hallucinogens
Volatile Inhalants
Cannabis
Others/Missing
74.6
0.5
0.3
2.7
1.3
0.6
13.1
6.9
60.4
0.5
0.4
1.9
1.9
1.1
22.3
11.5
46 24
65
7
82
3
23.6 21.1
All Treatments First Treatments
M F Total M F Total
3441 925 4396 1497 381 1887
Source: Drug Treatment Reporting System.  Health Research Board
No. of treatment demands
Mean age
Age (%) <25>35
Male/Female (%) 72/28 73/27
IV route of ad. main drug (%)
Primary Drug %
Opiates
Cocaine
Amphetamines
Hypnotics/Sedatives
Hallucinogens
Volatile Inhalants
Cannabis
Others/Missing
79.0
0.5
0.4
1.7
0.4
0.5
12.0
5.5
65.7
0.8
0.6
1.0
0.5
0.9
20.6
9.9
42.6 24.5
65
7
81
4
23.9 23.1 23.7 21.4 20.9 21.3
All Treatments First Treatments
M F Total M F Total
3445 1341 4865 1465 549 2041
Source: National Drug Treatment Reporting System.  Health Research Board
Characteristic
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Gender
Male
Female
Age
<25 years
>25 years
Mean Age
Age Left School
15 years and under
16 years and over
Still at school
Living Status
Family
Partner
Institution/Homeless
Alone
Other
Employment Status
Unemployed
Employed
Other
Treatment Contract
Number
1990
TT
73.7
26.3
74.7
25.3
76.8
23.2
80.7
19.3
76.4
23.6
79.2
20.8
76.1
23.9
79.6
20.4
79.3
20.7
83.5
16.5
78.8
21.2
79.7
20.3
70.6
29.4
70.2
29.8
49.3
50.7
69.0
31.0
45.4
54.6
74.5
25.5
48.1
51.9
77.9
22.1
55.8
44.2
81.3
18.7
61.0
39.0
84.2
15.8
65.3
34.6
82.1
17.9
63.7
36.3
82.0
18.0
25.2
72.1
24.9
3.1
52.1
26.4
5.4
10.2
5.9
81.8
9.9
8.2
2037 624 2359 450 2555 668 2919 859 2978 1150 3593 1396 3994 1499
76.8
11.0
12.1
81.5
10.7
7.7
66.6
17.3
16.1
81.4
11.1
7.5
70.0
16.2
13.8
82.3
10.0
7.5
78.0
11.2
10.7
83.7
9.8
6.4
81.8
17.7
0.6
87.2
9.8
3.0
80.3
13.6
6.1
86.4
9.2
4.4
79.9
11.9
8.2
61.2
17.3
5.4
11.9
4.2
56.9
25.3
3.2
7.1
7.5
73.8
11.4
4.7
5.4
4.7
60.6
21.7
3.7
6.8
7.2
73.1
10.8
6.0
3.9
6.1
61.7
22.5
3.2
6.1
6.4
73.3
13.4
3.8
2.7
6.8
67.4
18.7
2.4
5.8
5.7
77.2
9.8
3.1
4.0
5.9
70.8
16.2
3.5
4.5
5.0
81.2
9.0
2.8
3.1
3.9
69.6
17.3
3.5
3.5
6.1
77.7
10.4
3.9
2.6
5.4
65.9
26.5
7.6
69.7
26.3
4.0
51.5
33.9
14.5
67.9
27.8
4.2
56.3
32.2
11.5
66.5
29.2
4.3
57.4
33.6
8.9
60.4
34.5
5.1
50.3
41.1
8.7
62.6
34.4
3.0
57.2
36.8
5.9
61.6
34.7
3.7
56.0
36.9
7.1
22.8 25.5 21.9 25.3 21.5 24.5 21.1 23.8 20.6 23.6 20.7 23.8 21.1
FT TT FT TT FT TT FT TT FT TT FT TT FT
1991 1992 1993 1994 1995 1996
Table B9: Dublin.  Characteristics of treated drug misusers.  Valid percentages.
Total Treatment (TT), First Treatment (FT).
Source: National Drug Treatment Reporting System, Health Research Board.
*1996
Drug
Drug
90
Heroin
MST
Methadone
Cocaine
Ecstasy
Benzodiazepines
LSD
Volatile Inhalants
Cannabis
Other Drugs
Valid N
Total N
1990 1991 1992 1993 1994 1995 *1995 *1996
%
39.3
33.0
1.4
0.8
0.0
3.0
0.4
2.4
11.5
8.0
2021
2036
37.0
30.6
3.0
0.4
0.3
3.1
0.6
2.2
12.6
10.3
2337
2359
37.9
26.8
3.9
0.4
2.0
2.0
1.3
2.3
14.1
9.1
2546
2555
48.3
22.5
5.0
0.7
3.5
1.2
1.7
1.1
10.4
5.6
2896
2919
55.7
18.5
4.4
0.3
2.5
0.7
1.4
0.7
10.1
5.6
2970
2978
70.6
10.6
3.8
0.3
3.0
1.8
0.8
0.4
6.6
2.2
3587
3593
60.7
9.0
3.2
0.5
6.5
2.2
1.1
0.7
13.2
2.9
4390
4396
69.5
4.4
3.6
0.5
5.3
1.2
0.4
0.5
12.0
2.6
4858
4865
% % % % % % %
Table B10: Dublin and Ireland.
All Treatment Contacts.  Primary Drug 1990 - 1996.  Valid Percentages.
* Ireland.   Source: Drug Treatment Reporting System, Health Research Board
Other Drugs
Volatile Inhalants
Heroin
MST
Methadone
Cocaine
Ecstasy
Benzodiazepines
LSD
Cannabis
**Valid N
Total N
1990 1991 1992 1993 1994 1995 *1995
%
17.9
18.8
3.7
1.6
0.2
4.4
1.0
0.5
14.3
24.5
1641
2037
14.4
15.1
3.7
1.3
0.6
8.2
1.6
0.6
22.2
19.6
1720
2359
12.7
13.5
4.9
1.3
3.3
9.4
3.6
0.6
22.6
17.5
1832
2555
11.9
13.9
9.0
1.1
3.6
6.6
3.4
0.4
20.5
21.5
2367
2919
9.5
10.0
14.6
2.0
5.2
6.2
2.6
0.5
21.7
22.6
2392
2978
11.0
10.5
19.8
2.1
8.1
18.8
1.5
0.3
20.2
4.2
2829
3593
9.3
8.6
16.6
2.0
10.0
16.0
3.8
0.3
21.3
5.1
3490
4396
6.5
6.0
15.4
3.4
10.7
21.3
2.4
0.3
22.0
13.1 12.7 10.6 8.1 5.1 3.5 7.0 6.9
5.1
3565
4865
% % % % % % %
Table B11: Dublin and Ireland.
All Treatment Contacts.  Secondary Drug 1990 - 1996.  Valid Percentages.
* Ireland.   ** Valid N excludes missing and no secondary drug.      
Source: Drug Treatment Reporting System, Health Research Board
Alcohol
Cause of death
Risk Category
Cumulative
Total
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Drug dependence
(ICD-9 code 304)
Poisoning
(ICD-9 code 965)
Total
1985
14
8
22
1986
3
5
8
1987
3
4
7
1988
5
10
15
1989
4
4
8
1990
4
7
11
1991
4
10
14
1992
13
4
17
1993
9
11
20
1994
15
4
19
*1995
25
6
31
*1996
33
7
40
Table B12: Ireland.  Mortality.  Drug Dependence & Poisoning.  1985 - 1996  Ages 15 - 49 years.  Numbers
Table B13: Ireland  AIDS Cases and Deaths by Risk Category.  1982 - 1996
* Preliminary data.   Source: Central Statistics Office.
Source: Department of Health & Children/Virus Reference Laboratory
1982-1992 1993 1994 1995 1996 1997
Cases Deaths Cases Deaths Cases Deaths Cases Deaths Cases Deaths Cases Deaths Cases Deaths
142 61 43 21 22 27 25 27 34 17 10 1 276 154
109 45 13 14 27 11 16 11 34 16 12 3 211 100
52 27 12 9 18 6 13 8 11 1 8 2 114 53
5 3 0 0 0 0 1 0 0 0 2 1 8 4
308 136 68 44 67 44 55 46 79 34 32 7 609 311
IV Drug Use Related
Homo/Bisexual
Haemophilliacs/Heterosexuals/Babies born to
Heterosexual Mothers/Transfusion Recipient
Undetermined
Total
ICD-9 ***
92
337
67
292.0 - 292.9
Primary 19 32 27
42 41 40
61 73
255 255 213
378 604 942
633 859 1155
40 41 16
499 533 321
539 574
1233 1506 1559
0.3 0.4 0.4
563,846 607,841 624,094
0.2 0.2 0.2
Secondary
Sub-Total
304.0 - 304.9
Primary
Secondary
Sub-Total
305.2 - 305.9
Primary
Secondary
Sub-Total
Total Number
Rate per 1,000 population
All discharges
Percentage drug-related discharges
1994 1995 1996
*** International Classification of Diseases Codes (ICD-9)
292 Drug Psychosis
304 Drug Dependence
305 Non-dependent abuse excluding alcohol & tobacco.
The totals represent approximately 92% (1994), 96% (1995), 98% (1996) national coverage.
Source: Hospital In-Patient Enquiry System, Economic and Social Research Institute.
Table B14:  Ireland.  
Discharges from Acute Hospitals 1994 - 1996.
Primary and Secondary Diagnoses.  All Ages.  Numbers
ICD-9***   ICD-10****
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292.0 - 292.9
Primary 62
4
66
78
14
92
103
17
120
92
16
108
23
4
27
-
-
-
170
60
230
170
92
262
186
85
271
216
102
318
14
30
44
1
-
1
34
27
61
29
28
57
42
18
60
71
21
92
10
2
12
-
-
-
357
0.1
411
0.1
451
0.1
518
0.1
672
0.2
590
0.2
687
0.2
27765 27913 27148 27005 26687 26440 26656
1.3 1.5 1.7 1.9 2.5 2.2 2.6
Secondary
Sub-Total
304.0 - 304.9
Primary
Secondary
Sub-Total
305.2 - 305.9
Primary
Secondary
Sub-Total
Total Number
Rate per 1,000 population
All admissions
Percentage drug-related
admissions
1990 1991 1992 1993 1994 1995 1996
-
-
-
-
-
-
-
-
-
-
-
-
466
123
589
492
97
589
564
123
687
F11 - F16 - F18 - F19 - F55
Primary
Secondary
Sub-Total
*** International Classification of Diseases Codes (ICD-9)
292 Drug Psychosis
304 Drug Dependence
305 Non-dependent abuse excluding alcohol & tobacco.
**** International Classification of Diseases (ICD-10)
F11 - F16, F18, F19 Mental & Behavioural disorders due to psychoactive substance use.
F55 Abuse of non-dependence producing substances..
Source: National Psychiatric In-Patient Reporting System, Health Research Board.
Table B15:  Ireland.  
All Admissions to Irish Psychiatric Hospitals & Units 1990 - 1996.
Primary & Secondary Diagnoses.  All ages.  Numbers.
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Annex C
Summary of Projects Funded under the Science
and Technology Against Drugs Initiative
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Social Sciences
• Drugs, Community and Young People’s Choices
Why do some people turn to drugs and other don’t?  Poverty
and social deprivation are no doubt important but other factors
such as educational and recreational facilities and amenities
and community development could also influence the
situation.  The survey will look at 120 young people in a
disadvantaged part of Dublin’s inner city, to find out what
influences young people in vulnerable communities.
Contact: Mr. Barry Cullen, The Children’s Centre,
Trinity College Dublin.
• Identification of Critical Mediating Variables in Initiation
to
Drug use among Adolescents
Little is known about what leads young people to take drugs
for the very first time.  This study will look at the factors that
might be important such as peer pressure, experiments with
legal drugs (alcohol, cigarettes), easy access to illegal drugs
and individual attitudes and behaviours, as well as asking if
different people respond differently to these factors.
Contact: Dr. Mark Morgan, St. Patrick’s College,
Drumcondra, Dublin 9.
• A Social Study of Drug Education
How effective are educational programmes at preventing
young people from misusing drugs.  This study will evaluate
the drugs programmes that are used here and abroad.  The
results will be used in designing new educational programmes
and these will then be tried on a pilot basis as part of this
project.
Contact: Ms. Elizabeth Kiely, Applied Social Studies,
University College Cork.
• Ecstasy Use among young Irish People
Who is buying ecstasy or why?   How old are they?  Where do
they get their tablets?  Do they use other drugs?  What is their
Annex C
attitude to the law?   These and other questions will be asked
in this study of young ecstasy users in Dublin (in a
disadvantaged and an affluent area), in Cork city and
Dungarvan.  Findings will be compared with those from the
Netherlands and Sweden.
Contact: Dr. Patrick O’Mahony, Centre for European Social
Research, and Mr. Tim Murphy, Department of Law,
University College Cork.
• Drug Misuse in Dublin - A capture-recapture study to
estimate age, sex and prevalence of drug users
Heroin addicts are a hidden population.  This survey will use
a range of sources to estimate the number of heroin users in
Dublin, their age, the proportion of men and women, and if
possible the percentage that are a HIV positive.
Contact: Dr. Catherine Comiskey, Department of Applied
Science, Regional Technical College Tallaght, Dublin.
• Pathways to and outcomes of Methadone treatment
programmes
in the Dublin area
A survey of people attending three Dublin methadone clinics
to investigate if programmes reduce drug taking, criminal
activity and HIV infection and if they improve people’s health
and employment prospects.  The study will also provide an
insight into the paths that lead first to addiction, then to
methadone treatment, and will also identify if there are other
needs such as training and personal development.
Contact: Ms. Evelyn Mahon, Sociology Department,
Trinity College Dublin.
• The Social and Psychological needs of children of Drug
Users
The welfare of children of drug using parents is of growing
concern.  This survey will examine how children are affected
by their parents’ habit, whether they have special needs when
it comes to social services, and if they are more likely to take
drugs themselves.
Contact: Dr. Diane Hogan, The Children’s Centre,
Trinity College Dublin.
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• Prevalence, Profiles and Policy: A case-study of drug
use in
Dublin’s North Inner City
This in-depth study will begin by trying to estimate the number
of drug users in Dublin using survey and in-depth interviews.
The emphasis will be on interviewing those who are not
attending treatment centres and on women drug users about
whom little is known.
Contact: Dr. Jo Murphy-Lawless, Centre for Women’s
Studies,
Trinity College Dublin.
Biochemistry and Pharmacology
• MDMA Toxicity: The influence of Metabolic Genotype at
CYP2D6
Some people react very severely to ecstasy, these reactions
are rare but can also be fatal.  Some 3% of people lack a
particular enzyme (called cytochrome P450) that may be
important in helping the body to cope with or process the drug.
If there is not enough enzyme present even a small dose
could be overwhelming.  This project will continue over two
years and will study people who have reacted badly to
ecstasy to see if they possess this faulty enzyme.  If this
theory is right, then it should be possible to predict in advance
who is at risk and so help minimise the danger.
Contact: Dr. Michael Gill, Psychiatry and Genetics,
Trinity College Dublin.
• Assessment of the Neurotoxicity of Ecstasy 3, 4
Methylenedioxy-Methamphetamine (MDMA), at levels
likely to
result from its recreational use
A side effect of ecstasy is that it can damage brain cells, but
not much is known about how and when this happens.  This
study will attempt to understand the toxic effects of ecstasy,
and how much damage is done by a single dose and how
much by repeated use.
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Contact: Prof. Keith Tipton, Biochemistry,
Trinity College Dublin.
• Neurotoxicity of Ecstasy-like drugs
Ecstasy tablets may be sold as ‘ecstasy’, or they may contain
impurities such as other drugs, including caffeine,
paracetamol and even a general anaesthetic called Ketamine.
In addition the tablet would probably be taken with other drugs
like alcohol, nicotine and cannabis.  This project will study the
effects of these drugs when taken together, a cocktail which
could cause liver and brain damage, and may explain why
some people react severely to even small doses.
Contact: Dr. Kathy O’Boyle, Pharmacology Department,
University College Dublin.
• Biochemical Pathways involved in Recrudescence of IV
drug use 
in ex-IV drug users treated with Interferon for Hepatitis C
Hepatitis C is a serious problem among IV drug users.  It can
generally be treated with interferon, but this can cause
depression and other serious side effects similar to heroin
withdrawal symptoms.  Consequently some patients go back
on heroin.  This project will conduct clinical trials with former
addicts to see if it is possible to block the distressing effects of
interferon.
Contact: Dr. Dermot Kelleher, Hepatology Department,
St. James’s Hospital, Dublin.
• Pharmaceutical Strategies aimed to alleviate the Opiate
Withdrawal Syndrome
Withdrawal symptoms are a major problem for heroin addicts.
This project will first study what is actually happening at a
physiological level in an addict’s body during both addiction
and withdrawal; then using that information, identify and test
other drugs that might alleviate symptoms.
Contact: Dr. Ciaran Regan, Pharmacology Department,
University College Dublin.
• Long Term Toxicity of MDMA - evaluation of hidden risks
This team, alongside the Eastern Health Board’s drug
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addiction centres, will investigate how long term ecstasy use
affects the body’s nervous system.
Contact: Drs. Alan Baird, Gethin McBean and Alan Keenan,
Pharmacology Department, University College Dublin. 
• The Cardiovascular actions of Cocaine and Ecstasy in
Human
and Animal Tissues
Cocaine and ecstasy can affect a person’s heart rate, blood
pressure and nervous system with potentially fatal results.
Although cocaine has been widely studied, little is known
about its actual effects on the heart and even less about
ecstasy.  This project hopes to improve our understanding in
this area by studying the toxic effects of these drugs on heart
tissue and veins.
Contact: Prof. James Docherty,
Royal College of Surgeons, Dublin.
Detection and Analysis
• Development of Immunosensors for Detection of
Ecstasy and 
its Analogues in Serum and Urine
An investigation into assessing different techniques which
could be used to detect ecstasy and its derivatives in blood
and urine samples.  Their aim: to develop a pocket instrument
that uses disposable strips to detect ecstasy, and which could
be used by first aid teams, ambulance and casualty staff.
Contact: Prof. George Guilbault, Chemistry Department,
University College Cork.
• Automated Analysis of Controlled Drugs in Biological
Samples 
with GCIMS Detection
An investigation into new and faster ways of extracting a
range of drugs from biological samples for use in forensic
testing.
Contact: Prof. John Corish, Department of Chemistry,
Trinity College Dublin.
100
Annex C
• Development of a Diagnostic Test with increased
specificity
and sensitivity for the detection of Amphetamines
and/or Benzodiazepines
Screening for drug use among patients is important in both
diagnosing abuse and treating it.  Problems exist in the
present technique, this is an investigation into a new
approach using immunology: in essence, testing for the
presence of antibodies to the particular drug. 
Contact: Dr. Alan Shattock, Medical Microbiology,
University College Dublin.
• The Analytical Profiling of Drugs of Abuse
An analysis of a range of drugs to identify their characteristics
e.g. the exposure of illegal drugs to different environments -
cannabis can spend time in the sea, while the level of active
ingredient (THC) will depend on where the plant was grown.
The resulting ‘drugs intelligence’ will be used in the analysis
of seizures - how the drug was made, stored and distributed.
Contact: Dr. Desmond Corrigan, School of Pharmacy,
Trinity College Dublin.
• An Attempt to Profile the Ecstasy Class of Controlled
Substances
Dozens of different formulations of ecstasy exist depending
on raw materials and the process used to make the tablets.  If
more was known about the chemistry of ecstasy it might be
possible to identify the illicit laboratories involved and their
suppliers.  This project will analyse 64 different types of
ecstasy and ecstasy-intermediates.  This will produce an
ecstasy reference library or databank that forensic
laboratories can consult to facilitate fingerprinting of ecstasy
seizures.
Contact: Dr. Patrick Guiry, Chemistry Department,
University of Dublin.
• Analysis and Profiling of Illicit Drugs using High-
resolution 
Chromatographic and Mass Spectrometric methods
The development of new tests for seizures of heroin, cocaine,
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ecstasy and other amphetamines that are capable of
detecting the active ingredients, any impurities present and
new variants arriving on the scene.  
Contact: Prof. James Heffron, Biochemistry Department,
University College Cork.
• Development and Evaluation of Novel sensor
Technology for 
Screening of Suspected Illicit Drugs
A range of different sensors are used today in industry,
medicine and environmental monitoring - including one type
known as the artificial nose.  This project will investigate if any
of the existing approaches can be adapted for use with illegal
drugs.  If an accurate and reliable drug sensor can be
produced (first hoping to develop a heroin sensor) then a
small portable instrument would be available for field use.  
Contact: Dr. Dermot Diamond, BEST Centre,
Dublin City University.
• Development of a Biosensor to Detect Cocaine, Ecstasy
and 
Amphetamines
In recent years scientists at Trinity College Dublin studied
what happens to ecstasy when it’s inside the human body.
This project hopes to exploit that new knowledge and develop
a new kind of sensor.  If successful, the sensor would be
portable, highly specific and capable of  detecting ecstasy,
cocaine and the other amphetamines.
Contact: Prof. Clive Williams, Biochemistry Department,
and Prof. Werner J. Blau, Physics Department,
Trinity College Dublin.
• Development of a Multichannel Biosensor for the
Detection and
Analysis of Drugs of Abuse
Many forensic tests currently done at the laboratory could be
done on location e.g. on board ship, if appropriate portable
instruments, sensors or kits were available.  The BEST
Centre together with scientists from the BEST at the
University of Ulster are evaluating a variety of sensor
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Drugs Services Provided by
Eastern Health board*
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PROGRAMME MANAGER
3 AREA OPERATIONS MANAGERS
EXISTING SERVICES
! Detoxification Beds
! Addiction Centres
! Satellite Clinics
! Community Board
! Mobile Clinics
! STD Clinics
! Gay Men Health Project/
Womens Health Project
! After Care/Rehabilitation
! Education
! Help Line
! Young Persons
Programme
FURTHER DEVELOPMENTS
PLANNED
! Detoxification Beds
! Addiction Centres
! Satellite Clinics
! STD Clinics
! Gay Men Health Project/
Womens Health Project
! After Care/Rehabilitation
! Education
! Help Line
! Young Persons
Programme
PLANNED SERVICES
! Emergency Assessments
! In Patient Stabilisation
! Support Workers
! Information Systems
! Voluntary Organisations
! Evaluation
PLANNED SERVICES
& EXPANSION
*- Health Board with the largest
catchment population in Ireland
- Catchment Population 1,245,225
- Treats 88% of “treated durg
misusers”
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Overview of Drug Issues in Ireland, 1997
Introduction
The Drugs Research Division of the Health Research Board is
involved in national and international activities in the area of
drug misuse. The Division is funded by national, EU sources
and contract research.
Activities at the National and Regional Levels
National Information Sources on Drug Misuse
Contact:  Mary O’Brien
National Drug Treatment Reporting System
The Drugs Research Division of the Health Research Board
oversees the maintenance and development of a national
epidemiological database on treated drug misuse in Ireland i.e.
the National Drug Treatment Reporting System - NDTRS. The
system collects data on treated drug misuse throughout the
country (e.g. number of contacts; types, duration and frequency
of drug use;  socio-demographic characteristics and living
situation of treated drug misusers; risk behaviour). The data
gathered is analysed and presented in annual reports on
Treated Drug Misuse in Ireland.
National Indicators of Drug Misuse
The Drugs Research Division compiles information on a number
of indirect indicators of drug misuse e.g.  Health data such as,
drug-related AIDS/HIV cases, deaths, admissions/discharges to
psychiatric hospitals and general hospitals; Data in the area of
law enforcement e.g. information regarding the price, purity,
number and quantity of illicit drugs seized and the number of
persons charged for drug offences. 
National Report on Drug Issues in Ireland
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The Drugs Research Division produces an annual National
Report on Drug Issues in Ireland. The report provides an
overview of drugs policy; drug monitoring systems and sources
of information; demand reduction initiatives; evaluation, research
and training activities; future information needs.
Research Projects
Contact:  Rosalyn Moran
The Drugs Research Division is increasing its research portfolio.
The following studies have been started recently.
A Study of the Feasibility of the Inclusion of General Practitioners and
Prisons in the National Drug Treatment Reporting System - NDTRS
While the National Drug Treatment Reporting System run by
the HRB provides ‘good’ coverage of treated drug misuse in
Ireland, it is important given its role as a national information
resource and framework for policy formulation that coverage is
as near ‘complete’ as possible. There is an important gap in
existing coverage which the study aims to address.
The study will determine the feasibility of the inclusion of two
specific groups i.e. drug misusers treated by the Prison and GP
services, in the NDTRS. In so far as the study endorses the
feasibility of inclusion, preliminary steps to the implementation of
NDTRS in the two situations will be put in place. The study
should result in a more representative picture of treated drug
misuse in Ireland.  [Contact : Petrina Duff].
Knowledge, Attitudes and Beliefs regarding Drugs and Drug Users -
A National Sample amongst the General Public
A survey of Knowledge, Attitudes and Beliefs regarding Drugs
and Drug Users is underway. The study aims to ascertain 
- the attitudes of the general public to illicit drugs and drug
users
- the general public’s knowledge of and experience with drugs
- attitudes to prevention and to different forms of treatment
- the general public’s perception of the personal and societal
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consequences 
of drug misuse.
A nation-wide sample of respondents randomly selected from
the electoral register  has been carried out. The results will be of
interest inter alia, to academic researchers, policy makers and
public health personnel. [Contact : Audrey Bryan].
Relation between Drug Use, Impaired Driving and Traffic Accidents
A literature review is being conducted which will address a] the
experimental and laboratory evidence in relation to the effects of
different drugs on driving skills b] the evidence from field studies
of a relation between drug use and traffic accidents and c]
existing and proposed drug testing procedures with regard to
driving in the EU and the issues raised by such testing. The
study is being carried out in co-operation with the Transport
Policy Research Institute, UCD. [Contact : Ros Moran].
Drug Misuse in its Social and Economic Context
This two-year research project is nearing completion. The
objective of the study is to gain an holistic understanding of the
nature and patterns of drug use and to evaluate the relationship
between problematic drug use and social and economic
deprivation.   A combination of quantitative and qualitative
research methods are being used and results will be analysed
for trends which indicate the factors contributing to prolonged
problematic drug use.
[Contact : Aileen O’Gorman].
Availability, Use and Evaluation of the Provision of Crèche Facilities
in Association with Drug Treatment
The study will explore crèche facilities in drug treatment
environments - their provision, usage, types of  users,
programmes provided etc. with a view to providing
recommendations which would feed into discussions regarding
the future planning and development of  such crèche facilities.
Semi- structured interviews will be conducted with the four
groups associated with the drug treatment services -  treatment
staff, crèche leaders,  parents and/or guardians of  users, users
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i.e. children of problem drug users.
[Contact : Ros Moran].
Information and Dissemination Activities
Information and Dissemination Policy
The Drugs Research Division has recently developed an
Information and Dissemination Policy document which
discusses inter alia
! information provision relating to drugs to a range of actors in
the national context. Ongoing information provision includes
response to routine enquiries from a wide range of actors
(media, government, health professionals, general public);
HRB publications; presentations at conferences etc.
! the role of the Drugs Research Division as a conduit for
information emanating from the European Monitoring Centre
for Drugs and Drug Addiction (scientific reports, research
tenders);  the Commission of the European Communities
(including drug related Research and Development
Programmes) and the Pompidou Group of the Council of
Europe. 
The Drugs Research Division maintains and is further
developing a number of mailing lists to serve the Information
and Dissemination function.
Bibliography - Drug Misuse in Ireland
An annotated bibliography of drugs issues in Ireland is
maintained.  This includes books, monographs and non-
governmental reports; departmental reports and information;
journal articles on studies of drug misuse.  A summary of
relevant legislation is also included.
International and European Collaboration
European Monitoring Centre for Drugs and Drug Addiction - EMCDDA
The European Monitoring Centre for Drugs and Drug Addiction
is an European Community institution providing information at
Annex E
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European level concerning drugs and drug addiction and their
consequences. The EMCDDA works to improve the
comparability of drug related data in the Member States;
disseminates information and co-operates with international
bodies dealing with drug related issues. 
The EMCDDA in fulfilling its role, co-operates with a network
of ‘Focal Points’ or national centres dealing with drug related
issues in the Member States. This network is called the REITOX
network (European Information Network on Drugs and Drug
Addiction). The Drugs Research Division is the designated Irish
Focal Point  of the REITOX network. Focal Points act as an
information resource to the EMCDDA in relation to the national
situation in each Member State. The Focal Point participates in
several projects aiming to co-ordinate and standardise drugs
related information collection in the EU.
Current contractual obligations of the Irish Focal Point in the
EMCDDA context includes the completion of an annual report
on Drugs in Ireland;  provision of epidemiological information on
an annual basis; participation in a number of ad hoc research
and information tasks e.g. current projects include development
of Irish component of an European Database of Demand
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Contact Points
Ms. Rosalyn Moran; Ms. Mary
O’Brien;
Head of Unit. S e n i o r
Researcher.
Email : rmoran@hrb.ie Email :
mary@hrb.ie
The Health Research Board
73 Lower Baggot Street, Dublin 2, Ireland
